Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

Prof. Dr. med. Bastian von Tresckow

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Kuruvilla, John; Armand, Philippe; Herrera, Alex F.; Ribrag, Vincent; Thieblemont, Catherine; von Tresckow, Bastian; Wang, Guoqing; Marinello, Patricia; Chakraborty, Samhita; Orlowski, Robert; Zinzani, Pier Luigi
    Allogeneic Stem Cell Transplantation in Participants With Hematologic Malignancies Following Pembrolizumab Therapy
    In: Transplantation and Cellular Therapy, Jg. 31, 2025, Nr. 6, S. 357.e1 – 357.e11
    DOI (Open Access)
  • Bröckelmann, Paul J.; Böll, Boris; Molin, Daniel; Schneider, Gundolf; Leppä, Sirpa; Meissner, Julia; Kamper, Peter; Hutchings, Martin; Christensen, Jacob H.; Schnetzke, Ulf; Fuchs, Michael; Jablonski, Janina; Eichenauer, Dennis A.; von Tresckow, Bastian; Klapper, Wolfram; Kobe, Carsten; Borchmann, Peter; Fosså, Alexander
    Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients
    In: HemaSphere: Open Access Journal of the European Hematology Association, Jg. 9, 2025, Nr. 8, e70190
    DOI (Open Access)
  • Bröckelmann, Paul J.; von Tresckow, Bastian
    Combined targeted modality in cHL : a risky bet?
    In: Blood, Jg. 145, 2025, Nr. 3, S. 249 – 251
    DOI (Open Access)
  • Bröckelmann, P.J.; Müller, H.; Fuchs, M.; Gillessen, S.; Eichenauer, D.A.; Borchmann, S.; Robertz, A.S.; Behringer, K.; Welters, J.; Ferdinandus, J.; Böll, B.; Tharmaseelan, H.; Yang, X.; Kobe, C.; Eich, H.T.; Baues, C.; Klapper, W.; Borchmann, P.; von Tresckow, Bastian
    Correction: Correlation of progression-free survival and overall survival after treatment for relapsed Hodgkin lymphoma: individual patient data analysis of randomized German Hodgkin Study Group (GHSG) Trials
    In: Leukemia, Jg. 39, 2025, Nr. 5, S. 1274
    DOI (Open Access)
  • Bröckelmann, P.J.; Müller, H.; Fuchs, M.; Gillessen, S.; Eichenauer, D.A.; Borchmann, S.; Jacob, A.S.; Behringer, K.; Momotow, J.; Ferdinandus, J.; Böll, B.; Yang, X.; Kobe, C.; Eich, H.-T.; Baues, C.; Klapper, W.; Engert, A.; Borchmann, P.; von Tresckow, Bastian
    Correlation between progression-free and overall survival in patients with Hodgkin lymphoma : A comprehensive analysis of individual patient data from randomized German Hodgkin Study Group (GHSG) trials
    In: Annals of Oncology, Jg. 36, 2025, Nr. 4, S. 393 – 402
    DOI (Open Access)
  • Bröckelmann, P.J.; Müller, H.; Fuchs, M.; Gillessen, S.; Eichenauer, D.; Borchmann, S.; Robertz, A.S.; Behringer, K.; Welters, J.; Ferdinandus, J.; Böll, B.; Tharmaseelan, H.; Yang, X.; Kobe, C.; Eich, H.T.; Baues, C.; Klapper, W.; Borchmann, P.; von Tresckow, Bastian
    Correlation of progression-free survival and overall survival after treatment for relapsed Hodgkin lymphoma : individual patient data analysis of randomized German Hodgkin Study Group (GHSG) Trials
    In: Leukemia, Jg. 39, 2025, Nr. 4, S. 988 – 990
    DOI (Open Access)
  • Ossami Saidy, Anna; Peczynski, Christophe; Thieblemont, Catherine; Daskalakis, Michael; Wehrli, Marc; Beauvais, David; Finke, Jürgen; Schorb, Elisabeth; Vandenberghe, Peter; Berning, Philipp; Stelljes, Matthias; Ayuk, Francis; Ram, Ron; Von Bonin, Malte; Dreger, Peter; Bethge, Wolfgang; Kuhnl, Andrea; Jost, Lasse; Stölzel, Friedrich; von Tresckow, Bastian; Renner, Christoph; Fuhrmann, Stephan; Galimard, Jacques‐Emmanuelle; Michel, Eva; Bazarbachi, Ali; Balari, Anna Sureda; Schmitz, Norbert; Glass, Bertram
    Efficacy and safety of CAR T‐cell therapy in patients with primary or secondary CNS lymphoma : A study on behalf of the EBMT and the GoCART coalition
    In: HemaSphere: Open Access Journal of the European Hematology Association, Jg. 9, 2025, Nr. 5, e70146
    DOI (Open Access)
  • Maulhardt, Markus; Call, Simon; Boyadzhiev, Hristo; Albici, Anca Maria; Hörster, Keven; Boquoi, Amelie; Janjetovic, Snjezana; Ossami Saidy, Anna; Teichert, Marcel; Brioli, Annamaria; Schultze-Florey, Christian; Heidel, Florian; Schindler, Philipp; Schub, Natalie; Aydilek, Enver; Stelljes, Matthias; Daskalakis, Michael; Krekeler, Carolin; Hasenkamp, Justin; Khandanpour, Cyrus; Bacher, Ulrike; Reinhardt, Hans Christian; Lenz, Georg; Stölzel, Friedrich; Pabst, Thomas; von Tresckow, Bastian; Wulf, Gerald; Berning, Philipp; Shumilov, Evgenii
    Efficacy of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma and prior central nervous system manifestation : A multicenter real-world analysis
    In: HemaSphere: Open Access Journal of the European Hematology Association, Jg. 9, 2025, Nr. 8, e70192
    DOI (Open Access)
  • von Tresckow, Bastian; Borchmann, Peter
    Entwicklungen in der Rezidivtherapie des diffusen großzelligen B-Zell-Lymphoms
    In: Die Onkologie, Jg. 31, 2025, Nr. 6, S. 543 – 549
    DOI
  • Haferkamp, Jennifer; Chodyla, Michal Kamil; Demircioglu, Aydin; Pabst, Kim M.; Jannusch, Kai; Hanoun, Christine; Umutlu, Lale; von Tresckow, Bastian; Schaarschmidt, Benedikt; Ludwig, Johannes M.; Grueneisen, Johannes; Milosevic, Aleksandar
    Evaluation of diffusion-weighted imaging datasets for the assessment of disease activity in lymphoma patients
    In: European Journal of Radiology, Jg. 193, 2025, 112423
    DOI (Open Access)
  • Borchmann, Peter; Jachimowicz, Ron D.; von Tresckow, Bastian
    Glofitamab with GemOx for diffuse large B-cell lymphoma
    In: Lancet, Jg. 406, 2025, Nr. 10513, S. 1726
    DOI
  • Watanabe, Masao; Fendler, Wolfgang; Grafe, Hong; Hirmas, Nader; Hamacher, Rainer; Lanzafame, Helena; Pabst, Kim M.; Hautzel, Hubertus; Aigner, Clemens; Kasper, Stefan; von Tresckow, Bastian; Stuschke, Martin; Kümmel, Sherko; Lugnier, Celine; Hadaschik, Boris; Grünwald, Viktor; Zarrad, Fadi; Kersting, David; Siveke, Jens T.; Herrmann, Ken; Weber, Manuel
    Head-to-head comparison of ⁶⁸ Ga-FAPI-46 PET/CT, ¹⁸F-FDG PET/CT, and contrast-enhanced CT for the detection of various tumors
    In: Annals of Nuclear Medicine, Jg. 39, 2025, Nr. 3, S. 255 – 265
    DOI
  • Merz, Maximilian; Albici, Anca-Maria; von Tresckow, Bastian; Rathje, Kristin; Fenk, Roland; Holderried, Tobias; Müller, Fabian; Tovar, Natalia; Oliver-Cáldes, Aina; Vucinic, Vladan; Kharboutli, Soraya; Bärmann, Ben-Niklas; Ayuk, Francis; Platzbecker, Uwe; Stölzel, Friedrich; Schub, Nathalie; Schmitz, Friederike; Fandrei, David; Born, Patrick; Khandanpour, Cyrus; Hanoun, Christine; Hörster, Keven; Teichert, Marcel; Jeker, Barbara; Hoffmann, Michele; Kröger, Nicolaus; de Larrea, Carlos Fernández; Pabst, Thomas; Gagelmann, Nico
    Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma : An international multicenter study
    In: HemaSphere: Open Access Journal of the European Hematology Association, Jg. 9, 2025, Nr. 1, e70070
    DOI (Open Access)
  • Dampmann, Maria; von Tresckow, Bastian; Reinhardt, Hans Christian; Küppers, Ralf; von Tresckow, Julia
    Insights into the pathogenesis and biology of chronic lymphocytic leukemia through analysis of its B-cell receptor
    In: Leukemia and Lymphoma, Jg. 66, 2025, Nr. 10, S. 1778 – 1787
    DOI (Open Access)
  • Shumilov, Evgenii; Scholz, Julia Katharina; Seib, Maximilian; Mazzeo, Paolo; Wurm-Kuczera, Rebecca; Vucinic, Vladan; Holtick, Udo; Boyadzhiev, Hristo; Melchardt, Thomas; Hölscher, Alexander; Schultze-Florey, Christian; Abdelhafez, Atef; Velazquez, Giuliano Filippini; Saidy, Anna Ossami; Lesan, Vadim; Schnetzke, Ulf; Kerkhoff, Andrea; Bacher, Ulrike; Ghandili, Susanne; Aydilek, Enver; Gebauer, Niklas; Weber, Thomas; Wulf, Gerald; Glass, Bertram; Thurner, Lorenz; Heidel, Florian H.; Schmid, Christoph; Viardot, Andreas; Hänel, Mathias; Dietrich, Sascha; Pabst, Thomas; Ayuk, Francis; von Tresckow, Bastian; Chapuy, Björn; Pott, Christiane; Müller, Fabian; Lenz, Georg
    Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma
    In: Blood Advances, Jg. 9, 2025, Nr. 15, S. 3955 – 3966
    DOI (Open Access)
  • Ferdinandus, Justin; Kaul, Helen; Fosså, Alexander; Hüttmann, Andreas; Keil, Felix; Ko, Yon-Dschun; Hitz, Felicitas; Schwarz, Michaela; Trenker, Corinna; Kerkhoff, Andrea; Staib, Peter; Wille, Kai; Dresel, Irmgard; Hahn, Dennis; Hertenstein, Bernd; Moosmann, Peter; Mey, Ulrich; Balabanov, Stefan; Armytage, Tasman; Roncolato, Fernando; Hellmuth, Johannes C.; Hertzberg, Mark; Kobe, Carsten; Klapper, Wolfram; Baues, Christian; Eich, Hans-Theodor; Kreissl, Stefanie; Fuchs, Michael; Jablonski, Janina; Schneider, Gundolf; Tharmaseelan, Hishan; Eichenauer, Dennis A.; von Tresckow, Bastian; Borchmann, Peter; Brockelmann, Paul J.
    Positron Emission Tomography-Guided Brentuximab Vedotin, Etoposide, Cyclophosphamide, Doxorubicin, Dacarbazine, and Dexamethasone in Older Patients with Advanced-Stage Classic Hodgkin Lymphoma : A Prospective, Multicenter, Single-Arm, Phase II Cohort of the German Hodgkin Study Group HD21 Trial
    In: Journal of Clinical Oncology (JCO), Jg. 43, 2025, Nr. 27, S. 2974 – 2985
    DOI
  • Kreuzberger, Nina; Goldkuhle, Marius; von Tresckow, Bastian; Kobe, Carsten; Sickinger, Marie-Therese; Monsef, Ina; Skoetz, Nicole
    Positron emission tomography-adapted therapy for first-line treatment in adults with Hodgkin lymphoma
    In: Cochrane Library, Jg. 2025, 2025, Nr. 3, CD010533
    DOI
  • von Tresckow, Bastian; Abrisqueta, Pau; Zamanillo, Irene; Pareja, Ángel Serna; Kuang, Yuting; Uyei, Jennifer; Shah, Mohsin; Walsh, Laura; Thorley, Eileen; Cantos, Krystal; Rashidi, Emaan; Hampp, Christian; Jalbert, Jessica J.; Archambault, Alexi N.; Xu, Yingxin; Aggarwal, Shivani; Ambati, Srikanth; Mohamed, Hesham; Ma, Qiufei; Jiménez-Ubieto, Ana
    Prognostic Factors and Effect Modifiers in Patients With Relapse or Refractory Diffuse Large B-Cell Lymphoma After Two Lines of Therapy : A Systematic Literature and Expert Clinical Review
    In: European Journal of Haematology, Jg. 115, 2025, Nr. 2, S. 104 – 116
    DOI (Open Access)
  • Abrisqueta, Pau; Jiménez-Ubieto, Ana; Serna, Ángel; Zamanillo, Irene; Kuang, Yuting; Uyei, Jennifer; Shah, Mohsin; Walsh, Laura; Thorley, Eileen; Cantos, Krystal; Rashidi, Emaan; Ma, Qiufei; Jalbert, Jessica J.; Archambault, Alexi N.; Xu, Yingxin; Aggarwal, Shivani; Ambati, Srikanth; Mohamed, Hesham; Hampp, Christian; von Tresckow, Bastian
    Prognostic factors and effect modifiers in patients with relapsed or refractory follicular lymphoma who failed at least two lines of therapy : A systematic literature and expert clinical review
    In: Annals of Hematology, Jg. 104, 2025, Nr. 9, S. 4357 – 4367
    DOI (Open Access)
  • Eichenauer, Dennis A.; Basaran, Aylin; Bühnen, Ina; Fuchs, Michael; von Tresckow, Bastian; Rosenwald, Andreas; Hansmann, Martin-Leo; Bernd, Heinz-Wolfram; Borchmann, Peter; Klapper, Wolfram; Hartmann, Sylvia
    Refining histopathological growth pattern-based risk group discrimination in nodular lymphocyte-predominant Hodgkin lymphoma : an analysis from the German Hodgkin Study Group: LYMPHOMA
    In: Leukemia, Jg. 39, 2025, Nr. 7, S. 1735 – 1743
    DOI (Open Access)
  • Merz, Maximilian; Gagelmann, Nico; Smaili, Samih; Flossdorf, Sarah; Sauer, Sandra; Scheid, Christof; von Tresckow, Bastian; Wulf, Gerald; Weisel, Katja; Blau, Igor Wolfgang; Engelhardt, Monika; Wäsch, Ralph; Schub, Natalie; Teipel, Raphael; Hecker, Judith; Waldschmidt, Johannes; Besemer, Britta; Baermann, Ben-Niklas; Call, Simon; Hansmann, Leo; Ayuk, Francis Ayuketang; Raab, Marc S.; Einsele, Hermann; Platzbecker, Uwe; Kröger, Nicolaus
    Remission conversion drives outcomes after CAR T-cell therapy for multiple myeloma : A registry analysis from the DRST
    In: Blood, Jg. 146, 2025, Nr. 14, S. 1677 – 1686
    DOI (Open Access)
  • Bröckelmann, P.J.; von Tresckow, Bastian
    Reply to the Letter to the Editor ‘Comments on the study of correlation between progression-free and overall survival in patients with Hodgkin lymphoma’ by Zeng et al.
    In: Annals of Oncology, Jg. 36, 2025, Nr. 4, S. 470 – 471
    DOI
  • Plattel, Wouter J.; Teesink, Sophie; Visser, Lydia; Voltin, Conrad-Amadeus; Kaul, Helen; Schlößer, Hans A.; Kroesen, Bart-Jan; Kobe, Carsten; von Tresckow, Bastian; Borchmann, Peter; Diepstra, Arjan; Bröckelmann, Paul J.
    Serum TARC dynamics during anti-PD1-based first-line Hodgkin lymphoma treatment : An analysis from the GHSG NIVAHL trial
    In: HemaSphere: Open Access Journal of the European Hematology Association, Jg. 9, 2025, Nr. 8, e70205
    DOI (Open Access)
  • Angelillo, Piera; Alarcon Tomas, Ana; Campodonico, Edoardo; Novak, Urban; Gabellier, Ludovic; Blau, Igor Wolfgang; Kwon, Mi; Ram, Ron; Forcade, Edouard; Besley, Caroline; Vucinic, Vladan; Kröger, Nicolaus; Corral, Lucía López; Vydra, Jan; Ferrari, Silvia; von Tresckow, Bastian; Rubio, Marie Therese; Hernani, Rafael; Sica, Simona; Stölzel, Friedrich; Rovira, Montserrat; Wagner-Drouet, Eva; Pérez-Simón, Jose Antonio; Castilla-Llorente, Cristina; Ferreri, Andres J. M.; Hoogenboom, Jorinde D.; Sanchez Ortega, Isabel; Malard, Florent; Kuball, Jürgen; Ruggeri, Annalisa
    Severe ICANS after CAR T-cell therapy and assessment of prevention with levetiracetam for seizure prophylaxis following CAR T-cell for DLBCL & PMBCL in Europe : A survey on behalf of the Cellular Therapy & Immunobiology Working Party (CTIWP) of the EBMT
    In: Bone Marrow Transplantation, Jg. 60, 2025, Nr. 1, S. 100 – 102
    DOI
  • Pagliuca, Simona; Malard, Florent; Mooyaart, Jarl E.; Daskalakis, Michael; Gabellier, Ludovic; Yakoub-Agha, Ibrahim; Ram, Ron; Besley, Caroline; Forcade, Edouard; Vucinic, Vladan; Corral, Lucía López; Vydra, Jan; von Tresckow, Bastian; Amat, Paula; Amrolia, Persis; Vandenberghe, Peter; Stölzel, Friedrich; Sica, Simona; Rubio, Marie Thérèse; Hoogenboom, Jorinde D.; Ortiz-Maldonado, Valentín; Nagler, Arnon; Kuball, Jürgen; Chabannon, Christian; Ruggeri, Annalisa
    The landscape of immune monitoring in CAR-T cell therapy : A comprehensive review and survey study by the Cellular Therapy and Immunobiology Working Party of the EBMT
    In: Blood Reviews, Jg. 71, 2025, 101272
    DOI (Open Access)
  • Alig, Stefan K.; Reinhardt, Christian; von Tresckow, Bastian
    Was ist gesichert in der Therapie des diffusen großzelligen B-Zell-Lymphoms?
    In: Die Innere Medizin, Jg. 66, 2025, Nr. 12, S. 1258 – 1266
    DOI
  • Pabst, Kim M; Weber, Manuel; Laschinsky, Christina; Sandach, Patrick; Bartel, Timo; Küper, Alina T; Kessler, Lukas; Trajkovic-Arsic, Marija; Eckstein, Markus; Gilman, Elena; Nader, Michael; Barbato, Francesco; Podleska, Lars; Hadaschik, Boris; Hamacher, Rainer; Kersting, David; von Ostau (N.), Nicola; von Tresckow, Bastian; Kaelberlah, Hans-Peter; Kesch, Claudia; Kuemmel, Sherko; Reinacher-Schick, Anke; Schuler, Martin; Siveke, Jens; Grünwald, Viktor; Herrmann, Ken; Fendler, Wolfgang P.
    [⁶⁸Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation : A single-centre, single-arm, interventional, phase 2 trial
    In: The Lancet Oncology, Jg. 26, 2025, Nr. 9, S. 1204 – 1214
    DOI (Open Access)
  • Flümann, Ruth; Hansen, Julia; Meinel, Jörn; Pfeiffer, Pauline; Wittkopf, Hannah Goldfarb; Lütz, Anna; Wirtz, Jessica; Möllmann, Michael; Zhou, Tanja; Tabatabai, Areya; Lohmann, Tim; Jauch, Maximilian; Beleggia, Filippo; Pelzer, Benedikt; Ullrich, Fabian; Höfmann, Svenja; Arora, Aastha; Persigehl, Thorsten; Büttner, Reinhard; von Tresckow, Bastian; Klein, Sebastian; Jachimowicz, Ron D.; Reinhardt, Hans Christian; Knittel, Gero
    An inducible Cd79b mutation confers ibrutinib sensitivity in mouse models of Myd88-driven diffuse large B-cell lymphoma
    In: Blood Advances, Jg. 8, 2024, Nr. 5, S. 1063 – 1074
    DOI (Open Access)
  • Borchmann, Peter; Ferdinandus, Justin; Schneider, Gundolf; Moccia, Alden; Greil, Richard; Hertzberg, Mark; Schaub, Valdete; Hüttmann, Andreas; Keil, Felix; Dierlamm, Judith; Hänel, Mathias; Novak, Urban; Meissner, Julia; Zimmermann, Andreas; Mathas, Stephan; Zijlstra, Josée M; Fosså, Alexander; Viardot, Andreas; Hertenstein, Bernd; Martin, Sonja; Giri, Pratyush; Scholl, Sebastian; Topp, Max S; Jung, Wolfram; Vucinic, Vladan; Beck, Hans-Joachim; Kerkhoff, Andrea; Unger, Benjamin; Rank, Andreas; Schroers, Roland; zum Büschenfelde, Christian Meyer; de Wit, Maike; Trautmann-Grill, Karolin; Kamper, Peter; Molin, Daniel; Kreissl, Stefanie; Kaul, Helen; von Tresckow, Bastian; Borchmann, Sven; Behringer, Karolin; Fuchs, Michael; Rosenwald, Andreas; Klapper, Wolfram; Eich, Hans-Theodor; Baues, Christian; Zomas, Athanasios; Hallek, Michael; Dietlein, Markus; Kobe, Carsten; Diehl, Volker
    Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21) : a randomised, multicentre, parallel, open-label, phase 3 trial
    In: Lancet, Jg. 404, 2024, Nr. 10450, S. 341 – 352
    DOI (Open Access)
  • Merz, Maximilian; Dima, Danai; Hashmi, Hamza; Ahmed, Nausheen; Stölzel, Friedrich; Holderried, Tobias A. W.; Fenk, Roland; Müller, Fabian; Tovar, Natalia; Oliver-Cáldes, Aina; Rathje, Kristin; Davis, James A.; Fandrei, David; Vucinic, Vladan; Kharboutli, Soraya; Baermann, Ben-Niklas; Ayuk, Francis; Platzbecker, Uwe; Albici, Anca-Maria; Schub, Nathalie; Schmitz, Friederike; Shune, Leyla; Khouri, Jack; Anwer, Faiz; Raza, Shahzad; McGuirk, Joseph; Mahmoudjafari, Zahra; Green, Kimberly; Khandanpour, Cyrus; Teichert, Marcel; Jeker, Barbara; Hoffmann, Michele; Kröger, Nicolaus; von Tresckow, Bastian; de Larrea, Carlos Fernández; Pabst, Thomas; Abdallah, Al-Ola; Gagelmann, Nico
    Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy
    In: Blood Cancer Journal, Jg. 14, 2024, Nr. 1, 214
    DOI (Open Access)
  • Werner, Rudolf; Haug, Alexander; Buske, Christian; Heidegger, Simon; Illert, Anna L.; Bassermann, Florian; Herhaus, Peter; Buck, Andreas; Duell, Johannes; Topp, Max S.; Kraus, Sabrina; Einsele, Hermann; Lapa, Constantin; Raderer, Markus; Lenz, Georg; Habringer, Stefan; von Tresckow, Bastian; Keller, Ulrich
    CXCR4-targeted Theranostics in Hematooncology : Opportunities and Challenges
    In: Nuklearmedizin = Nuclear Medicine, Jg. 63, 2024, Nr. 02, S. 57 – 61
    DOI (Open Access)
  • Neuendorff, Nina Rosa; Khan, Abdullah; Ullrich, Fabian; Yates, Samuel; Devarakonda, Srinivas; Lin, Richard J.; von Tresckow, Bastian; Cordoba, Raul; Artz, Andrew; Rosko, Ashley E.
    Cellular therapies in older adults with hematological malignancies : A case-based, state-of-the-art review
    In: Journal of Geriatric Oncology, Jg. 15, 2024, Nr. 3, 101734
    DOI (Open Access)
  • Goldkuhle, Marius; Kreuzberger, Nina; von Tresckow, Bastian; Eichenauer, Dennis A.; Specht, Lena; Monsef, Ina; Skoetz, Nicole
    Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early-stage Hodgkin’s lymphoma
    In: Cochrane Library, 2024, Nr. 12, CD007110
    DOI
  • Heger, Jan-Michel; Mammadova, Laman; Mattlener, Julia; Sobesky, Sophia; Cirillo, Melita; Altmüller, Janine; Kirst, Elisabeth; Reinke, Sarah; Klapper, Wolfram; Bröckelmann, Paul J.; Ferdinandus, Justin; Kaul, Helen; Schneider, Gundolf; Schneider, Jessica; Schleifenbaum, Julia Katharina; Ullrich, Roland T.; Freihammer, Max; Awerkiew, Sabine; Lohmann, Mia; Klein, Florian; Nürnberg, Peter; Hallek, Michael; Rossi, Davide; Mauz-Körholz, Christine; Gattenlöhner, Stefan; Bräuninger, Andreas; Borchmann, Peter; von Tresckow, Bastian; Borchmann, Sven
    Circulating Tumor DNA Sequencing for Biologic Classification and Individualized Risk Stratification in Patients With Hodgkin Lymphoma
    In: Journal of Clinical Oncology (JCO), Jg. 42, 2024, Nr. 35, S. 4218 – 4230
    DOI
  • Hirmas, Nader; Hamacher, Rainer; Sraieb, Miriam; Kessler, Lukas; Pabst, Kim M.; Barbato, Francesco; Lanzafame, Helena; Kasper, Stefan; Nader, Michael; Kesch, Claudia; von Tresckow, Bastian; Hautzel, Hubertus; Aigner, Clemens; Glas, Martin; Stuschke, Martin; Kümmel, Sherko; Harter, Philipp; Lugnier, Celine; Uhl, Waldemar; Hadaschik, Boris; Grünwald, Viktor; Siveke, Jens T.; Herrmann, Ken; Fendler, Wolfgang
    Diagnostic Accuracy of ⁶⁸Ga-FAPI Versus ¹⁸F-FDG PET in Patients with Various Malignancies
    In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 3, S. 372 – 378
    DOI (Open Access)
  • Dreyling, Martin; Fowler, Nathan Hale; Dickinson, Michael; Martinez-Lopez, Joaquin; Kolstad, Arne; Butler, Jason; Ghosh, Monalisa; Popplewell, Leslie; Chavez, Julio C.; Bachy, Emmanuel; Kato, Koji; Harigae, Hideo; Kersten, Marie José; Andreadis, Charalambos; Riedell, Peter A.; Ho, P. Joy; Pérez-Simón, José Antonio; Chen, Andy I.; Nastoupil, Loretta J.; von Tresckow, Bastian; María Ferreri, Andrés José; Teshima, Takanori; Patten, Piers E. M.; McGuirk, Joseph P.; Petzer, Andreas L.; Offner, Fritz; Viardot, Andreas; Zinzani, Pier Luigi; Malladi, Ram; Paule, Ines; Zia, Aiesha; Awasthi, Rakesh; Han, Xia; Germano, Davide; O'Donovan, Darragh; Ramos, Roberto; Maier, Harald J.; Masood, Aisha; Thieblemont, Catherine; Schuster, Stephen J.; Ferreri, Andrés JM
    Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma : ELARA trial update
    In: Blood, Jg. 143, 2024, Nr. 17, S. 1713 – 1725
    DOI (Open Access)
  • Heger, Jan-Michel; Mattlener, Julia; Schneider, Jessica; Gödel, Philipp; Sieg, Noëlle; Ullrich, Fabian; Lewis, Richard; Bucaciuc-Mracica, Teodora; Schwarz, Roland F.; Rueß, Daniel; Ruge, Maximilian I.; Montesinos-Rongen, Manuel; Deckert, Martina; Blau, Tobias; Kutsch, Nadine; Balke-Want, Hyatt; Weiss, Jonathan; Becker, Kerstin; Reinhardt, H. Christian; Hallek, Michael; Borchmann, Peter; von Tresckow, Bastian; Borchmann, Sven
    Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNA
    In: Blood, Jg. 143, 2024, Nr. 6, S. 522 – 534
    DOI
  • Philippe, Armand; Zinzani, Pier Luigi; Lee, Hun Ju; von Tresckow, Bastian; Moskowitz, Craig H.
    Erratum: Armand P, Zinzani PL, Lee HJ, et al. Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma.
    In: Blood, Jg. 144, 2024, Nr. 3, S. 341
    DOI
  • Armand, Philippe; Zinzani, Pier Luigi; von Tresckow, Bastian; Ahmed, Sairah; Moskowitz, Craig H.
    Erratum: van der Straten L, Stege CAM, Kersting S, et al. Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL. Blood. 2023;142(13):1131-1142. (Blood (2023) 142(13) (1131–1142), (S0006497123014982), (10.1182/blood.2023020195))
    In: Blood, Jg. 144, 2024, Nr. 3, S. 341
    DOI (Open Access)
  • Fuchs, Michael; Jacob, Anne Sophie; Kaul, Helen; Kobe, Carsten; Kuhnert, Georg; Pabst, Thomas; Greil, Richard; Bröckelmann, Paul J.; Topp, Max S.; Just, Marianne; Hertenstein, Bernd; Soekler, Martin; Vogelhuber, Martin; Zijlstra, Josée M.; Keller, Ulrich Bernd; Krause, Stefan W.; Dührsen, Ulrich; Meissner, Julia; Viardot, Andreas; Eich, Hans-Theodor; Baues, Christian; Diehl, Volker; Rosenwald, Andreas; Buehnen, Ina; von Tresckow, Bastian; Dietlein, Markus; Borchmann, Peter; Engert, Andreas; Eichenauer, Dennis A.
    Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma
    In: Leukemia, Jg. 38, 2024, Nr. 1, S. 160 – 167
    DOI (Open Access)
  • Siefen, Ann-Cathrine; Kurte, Melina Sophie; Jakobs, Florian; Teichert, Marcel; von Tresckow, Bastian; Reinhardt, Hans Christian; Holtick, Udo; Atta, Johannes; Jehn, Christian; Sala, Elisa; Warnecke, Anke; Hänel, Mathias; Scheid, Christof; Kron, Florian
    How to optimize the CAR-T Cell therapy process? : A group concept mapping analysis of preconditions for a frictionless process from a German multistakeholder perspective
    In: Frontiers in Oncology, Jg. 14, 2024, 1466803
    DOI (Open Access)
  • Hübel, Kai; Bower, Mark; Aurer, Igor; Bastos-Oreiro, Mariana; Besson, Caroline; Brunnberg, Uta; Cattaneo, Chiara; Collins, Simon; Cwynarski, Kate; Pria, Alessia D.; Hentrich, Marcus; Hoffmann, Christian; Kersten, Marie J.; Montoto, Silvia; Navarro, Jose-Tomas; Oksenhendler, Eric; Re, Alessandro; Ribera, Josep-Maria; Schommers, Philipp; von Tresckow, Bastian; Buske, Christian; Dreyling, Martin; Davies, Andy; The EHA and ESMO Guidelines Committees
    Human immunodeficiency virus-associated Lymphomas : EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    In: HemaSphere: Open Access Journal of the European Hematology Association, Jg. 8, 2024, Nr. 9, e150
    DOI (Open Access)
  • Hübel, K.; Bower, M.; Aurer, I.; Bastos-Oreiro, M.; Besson, C.; Brunnberg, U.; Cattaneo, C.; Collins, S.; Cwynarski, K.; Dalla Pria, A.; Hentrich, M.; Hoffmann, C.; Kersten, M.J.; Montoto, S.; Navarro, J.T.; Oksenhendler, E.; Re, A.; Ribera, J.-M.; Schommers, P.; von Tresckow, Bastian; Buske, C.; Dreyling, M.; Davies, A.; EHA and ESMO Guidelines Committees
    Human immunodeficiency virus-associated lymphomas : EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    In: Annals of Oncology, Jg. 35, 2024, Nr. 10, S. 840 – 859
    DOI (Open Access)
  • Müller-Meinhard, Berit; Seifert, Nicole; Grund, Johanna; Reinke, Sarah; Yalcin, Fatih; Kaul, Helen; Borchmann, Sven; von Tresckow, Bastian; Borchmann, Peter; Plütschow, Annette; Richter, Julia; Engert, Andreas; Altenbuchinger, Michael; Bröckelmann, Paul J.; Klapper, Wolfram
    Human leukocyte antigen (HLA) class I expression on Hodgkin–Reed–Sternberg cells is an EBV-independent major determinant of microenvironment composition in classic Hodgkin lymphoma
    In: HemaSphere: Open Access Journal of the European Hematology Association, Jg. 8, 2024, Nr. 6, e84
    DOI (Open Access)
  • Ullrich, Fabian; Bröckelmann, Paul J.; Turki, Amin T.; Khan, Abdullah M.; Chiru, Elena-Diana; Vetter, Marcus; von Tresckow, Bastian; Wirth, Rainer; Cordoba, Raul; Ortiz-Maldonado, Valentín; Fülöp, Tamas; Neuendorff, Nina
    Impact of immunological aging on T cell-mediated therapies in older adults with multiple myeloma and lymphoma
    In: Journal for ImmunoTherapy of Cancer, Jg. 12, 2024, Nr. 12, e009462
    DOI (Open Access)
  • Rosenbrock, Johannes; Kaul, Helen; Oertel, Michael; Celik, Eren; Linde, Philipp; Fan, Jiaqi; Eichenauer, Dennis A.; Bröckelmann, Paul J.; von Tresckow, Bastian; Kobe, Carsten; Dietlein, Markus; Fuchs, Michael; Borchmann, Peter; Eich, Hans Theodor; Baues, Christian
    Involved-site Radiation Therapy is Equally Effective and Less Toxic Than Involved-field Radiation Therapy in Patients Receiving Combined Modality Treatment for Early-stage Unfavorable Hodgkin Lymphoma : An Analysis of the Randomized Phase 3 HD17 Trial of the German Hodgkin Study Group
    In: International Journal of Radiation Oncology, Biology, Physics, Jg. 120, 2024, Nr. 5, S. 1344 – 1352
    DOI (Open Access)
  • Penack, Olaf; Dreger, Peter; Ajib, Salem; Ayuk, Francis; Baermann, Ben-Niklas; Bug, Gesine; Kriege, Oliver; Jentzsch, Madlen; Kobbe, Guido; Koenecke, Christian; Lutz, Mathias; Martin, Sonja; Schlegel, Paul-Gerhard; Schroers, Roland; von Tresckow, Bastian; Vucinic, Vladan; Subklewe, Marion; Bethge, Wolfgang; Wolff, Daniel
    Management of Patients Undergoing CAR-T Cell Therapy in Germany
    In: Oncology Research and Treatment, Jg. 47, 2024, Nr. 3, S. 65 – 75
    DOI (Open Access)
  • Voltin, Conrad-Amadeus; Paccagnella, Andrea; Winkelmann, Michael; Heger, Jan-Michel; Casadei, Beatrice; Beckmann, Laura; Herrmann, Ken; Dekorsy, Franziska J.; Kutsch, Nadine; Borchmann, Peter; Fanti, Stefano; Kunz, Wolfgang G.; Subklewe, Marion; Kobe, Carsten; Zinzani, Pier Luigi; Stelljes, Matthias; Roth, Katrin S.; Drzezga, Alexander; Noppeney, Richard; Rahbar, Kambiz; Reinhardt, H. Christian; von Tresckow, Bastian; Seifert, Robert; Albring, Jörn C.; Blumenberg, Viktoria; Farolfi, Andrea; Flossdorf, Sarah; Gödel, Philipp; Hanoun, Christine
    Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy
    In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 51, 2024, Nr. 5, S. 1361 – 1370
    DOI (Open Access)
  • Heger, Jan-Michel; d'Hargues, Yannick; Kleinert, Fanni; Mattlener, Julia; Weiss, Jonathan; Franzen, Fabian; Becker, Christian; Becker, Kerstin; Gödel, Philipp; Schmiel, Marcel; Meinel, Jörn; Flümann, Ruth; Simon, Florian; Reinhardt, H. Christian; Borchmann, Peter; Borchmann, Sven; Balke-Want, Hyatt; Knittel, Gero; von Tresckow, Bastian
    Noninvasive minimal residual disease assessment in relapsed/refractory large B-cell lymphoma using digital droplet PCR
    In: European Journal of Haematology, Jg. 112, 2024, Nr. 6, S. 957 – 963
    DOI (Open Access)
  • Watanabe, Masao; Fendler, Wolfgang; Grafe, Hong; Hirmas, Nader; Hamacher, Rainer; Lanzafame, Helena; Pabst, Kim M.; Hautzel, Hubertus; Aigner, Clemens; Kasper, Stefan; von Tresckow, Bastian; Stuschke, Martin; Kümmel, Sherko; Lugnier, Celine; Hadaschik, Boris; Grünwald, Viktor; Zarrad, Fadi; Siveke, Jens T.; Herrmann, Ken; Weber, Manuel
    Prognostic Implications of ⁶⁸Ga-FAPI-46 PET/CT-Derived Parameters on Overall Survival in Various Types of Solid Tumors
    In: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 7, S. 1027 – 1034
    DOI
  • Kurte, Melina Sophie; Siefen, Ann-Cathrine; Jakobs, Florian; Poos, Tabea; von Tresckow, Julia; von Tresckow, Bastian; Reinhardt, Hans Christian; Kron, Florian
    Time-dependent cost comparison and health economic impact analysis of second-line interventions for transplant-ineligible patients with relapsed or refractory diffuse large B cell lymphoma
    In: European Journal of Haematology, Jg. 113, 2024, Nr. 3, S. 371 – 383
    DOI (Open Access)
  • Kurte, Melina Sophie; Siefen, Ann-Cathrine; Jakobs, Florian; von Tresckow, Bastian; Reinhardt, Hans Christian; Kron, Florian
    Cost-effectiveness analysis of transplant-ineligible relapsed or refractory diffuse large B-cell lymphoma treatment options : Experience of the efficiency frontier approach
    In: European Journal of Haematology, Jg. 111, 2023, Nr. 6, S. 895 – 908
    DOI (Open Access)
  • Flümann, Ruth; Hansen, Julia; Pelzer, Benedikt W.; Nieper, Pascal; Lohmann, Tim; Kisis, Ilmars; Riet, Tobias; Kohlhas, Viktoria; Nguyen, Phuong-Hien; Peifer, Martin; Abedpour, Nima; Bosco, Graziella; Thomas, Roman K.; Kochanek, Moritz; Knüfer, Jacqueline; Jonigkeit, Lorenz; Beleggia, Filippo; Holzem, Alessandra; Büttner, Reinhard; Lohneis, Philipp; Meinel, Jörn; Ortmann, Monika; Persigehl, Thorsten; Hallek, Michael; Calado, Dinis Pedro; Chmielewski, Markus; Klein, Sebastian; Göthert, Joachim R.; Chapuy, Bjoern; Zevnik, Branko; Wunderlich, F. Thomas; von Tresckow, Bastian; Jachimowicz, Ron D.; Melnick, Ari M.; Reinhardt, Hans Christian; Knittel, Gero
    Distinct genetically-determined origins of Myd88/Bcl2-driven aggressive lymphoma rationalize targeted therapeutic intervention strategies
    In: Blood Cancer Discovery, Jg. 4, 2023, Nr. 1, S. 78 – 97
    DOI (Open Access)
  • Hirsch, Caroline; Goldkuhle, Marius; Ernst, Moritz; Monsef, Ina; von Tresckow, Bastian; Skoetz, Nicole; Kreuzberger, Nina
    Factors for predicting treatment success and severe adverse events of chimeric antigen receptor (CAR) T-cell therapy in relapsed or refractory diffuse large B-cell lymphoma
    In: Cochrane Library, Jg. 2023, 2023, Nr. 11, CD015162
    DOI
  • Hirmas, Nader; Hamacher, Rainer; Sraieb, Miriam; Ingenwerth, Marc; Kessler, Lukas; Pabst, Kim M.; Barbato, Francesco; Lückerath, Katharina; Kasper, Stefan; Nader, Michael; Schildhaus, Hans-Ulrich; Kesch, Claudia; von Tresckow, Bastian; Hanoun, Christine; Hautzel, Hubertus; Aigner, Clemens; Glas, Martin; Stuschke, Martin; Kümmel, Sherko; Harter, Philipp; Lugnier, Celine; Uhl, Waldemar; Niedergethmann, Marco; Hadaschik, Boris; Grünwald, Viktor; Siveke, Jens T.; Herrmann, Ken; Fendler, Wolfgang P.
    Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities
    In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 5, S. 711 – 716
    DOI (Open Access)
  • Armand, Philippe; Zinzani, Pier Luigi; Lee, Hun Ju; Johnson, Nathalie A.; Brice, Pauline; Radford, John; Ribrag, Vincent; Molin, Daniel; Vassilakopoulos, Theodoros P.; Tomita, Akihiro; von Tresckow, Bastian; Shipp, Margaret A.; Herrera, Alex F.; Lin, Jianxin; Kim, Eunhee; Chakraborty, Samhita; Marinello, Patricia; Moskowitz, Craig H.
    Five-year follow-up of KEYNOTE-087 : pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma
    In: Blood, Jg. 142, 2023, Nr. 10, S. 878 – 886
    DOI (Open Access)
  • Gagelmann, Nico; Wulf, Gerald Georg; Duell, Johannes; Glass, Bertram; van Heteren, Pearl; von Tresckow, Bastian; Fischer, Monika; Penack, Olaf; Ayuk, Francis; Einsele, Herrmann; Holtick, Udo; Thomson, Julia; Dreger, Peter; Kröger, Nicolaus
    Hematopoietic stem cell boost for persistent neutropenia after CAR T-cell therapy : a GLA/DRST study
    In: Blood Advances, Jg. 7, 2023, Nr. 4, S. 555 – 559
    DOI (Open Access)
  • Dreger, Peter; Holtick, Udo; Subklewe, Marion; von Tresckow, Bastian; Ayuk, Francis; Wagner, Eva; Wulf, Gerald; Marks, Reinhardt; Penack, Olaf; Schnetzke, Ulf; Koenecke, Christian; von Bonin, Malte; Stelljes, Matthias; Glass, Bertram; Baldus, Claudia D.; Vucinic, Vladan; Mougiakakos, Dimitrios; Topp, Max; Schroers, Roland; Wolff, Daniel; Thomas, Simone; Kröger, Nicolaus; Bethge, Wolfgang A.
    Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma : the GLA/DRST experience
    In: Bone Marrow Transplantation, Jg. 58, 2023, Nr. 2, S. 229 – 232
    DOI (Open Access)
  • Eichenauer, Dennis A.; Bühnen, Ina; Baues, Christian; Kobe, Carsten; Kaul, Helen; Greil, Richard; Moccia, Alden; Zijlstra, Joseé M.; Hertenstein, Bernd; Topp, Max S.; Just, Marianne; von Tresckow, Bastian; Eich, Hans-Theodor; Fuchs, Michael; Dietlein, Markus; Hartmann, Sylvia; Engert, Andreas; Borchmann, Peter
    Interim PET-guided treatment for early-stage NLPHL : A subgroup analysis of the randomized GHSG HD16 and HD17 studies
    In: Blood, Jg. 142, 2023, Nr. 6, S. 553 – 560
    DOI
  • Derigs, Patrick; Bethge, Wolfgang A.; Krämer, Isabelle; Holtick, Udo; von Tresckow, Bastian; Ayuk, Francis; Penack, Olaf; Vucinic, Vladan; von Bonin, Malte; Baldus, Claudia; Mougiakakos, Dimitrios; Wulf, Gerald; Schnetzke, Ulf; Stelljes, Matthias; Fante, Matthias; Schroers, Roland; Kroeger, Nicolaus; Dreger, Peter
    Long-Term Survivors after Failure of Chimeric Antigen Receptor T Cell Therapy for Large B Cell Lymphoma : A Role for Allogeneic Hematopoietic Cell Transplantation? A German Lymphoma Alliance and German Registry for Stem Cell Transplantation Analysis
    In: Transplantation and Cellular Therapy, Jg. 29, 2023, Nr. 12, S. 750 – 756
    DOI
  • Grund, Johanna; Iben, Katharina; Reinke, Sarah; Bühnen, Ina; Plütschow, Annette; Müller-Meinhard, Berit; Garcia Marquez, Maria A.; Schlößer, Hans A.; von Tresckow, Bastian; Kellermeier, Fabian; Borchmann, Peter; Engert, Andreas; Bröckelmann, Paul J.; Klapper, Wolfram
    Low B-cell content is associated with a CD73-low tumour microenvironment and unfavourable prognosis in classic Hodgkin lymphoma
    In: British Journal of Haematology, Jg. 201, 2023, Nr. 6, S. 1097 – 1102
    DOI (Open Access)
  • Tabatabai, Areya; Arora, Aastha; Höfmann, Svenja; Jauch, Maximilian; von Tresckow, Bastian; Hansen, Julia; Flümann, Ruth; Jachimowicz, Ron D.; Klein, Sebastian; Reinhardt, Hans Christian; Knittel, Gero
    Mouse models of diffuse large B cell lymphoma
    In: Frontiers in Immunology, Jg. 14, 2023, 1313371
    DOI, Online Volltext (Open Access)
  • Bröckelmann, Paul J.; Bühnen, Ina; Meissner, Julia; Trautmann-Grill, Karolin; Herhaus, Peter; Halbsguth, Teresa V.; Schaub, Valdete; Kerkhoff, Andrea; Mathas, Stephan; Bormann, Matthias; Dickhut, Andreas; Kaul, Helen; Fuchs, Michael; Kobe, Carsten; Baues, Christian; Borchmann, Peter; Engert, Andreas; von Tresckow, Bastian
    Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma : Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial
    In: Journal of Clinical Oncology (JCO), Jg. 41, 2023, Nr. 6, S. 1193 – 1199
    DOI (Open Access)
  • Voltin, Conrad-Amadeus; Gödel, Philipp; Beckmann, Laura; Heger, Jan-Michel; Kobe, Carsten; Kutsch, Nadine; Borchmann, Peter; Dietlein, Markus; Herrmann, Ken; Stelljes, Matthias; Rahbar, Kambiz; Lenz, Georg; Reinhardt, H. Christian; Teichert, Marcel; Noppeney, Richard; Albring, Jörn C.; Seifert, Robert; von Tresckow, Bastian; Flossdorf, Sarah; Hanoun, Christine
    Outcome Prediction in Patients With Large B-cell Lymphoma Undergoing Chimeric Antigen Receptor T-cell Therapy
    In: HemaSphere: Open Access Journal of the European Hematology Association, Jg. 7, 2023, Nr. 1, S. E817
    DOI (Open Access)
  • Fan, Jiaqi; Adams, Anne; Sieg, Noëlle; Heger, Jan-Michel; Gödel, Philipp; Kutsch, Nadine; Kaul, David; Teichert, Marcel; von Tresckow, Bastian; Bücklein, Veit; Goesmann, Gretha; Li, Minglun; Struve, Nathalie; Trommer, Maike; Linde, Philipp; Rosenbrock, Johannes; Celik, Eren; Penack, Olaf; Stuschke, Martin; Subklewe, Marion; Belka, Claus; von Bergwelt-Baildon, Michael; Borchmann, Peter; Marnitz, Simone; Baues, Christian
    Potential synergy between radiotherapy and CAR T-cells - a multicentric analysis of the role of radiotherapy in the combination of CAR T cell therapy
    In: Radiotherapy and Oncology (The Green Journal), Jg. 183, 2023, 109580
    DOI
  • Ayuk, Francis; Gagelmann, Nico; von Tresckow, Bastian; Wulf, Gerald; Rejeski, Kai; Stelljes, Matthias; Penack, Olaf; Baldus, Claudia D.; Kröger, Nicolaus; Bethge, Wolfgang; Dreger, Peter
    Real-world results of CAR T-cell therapy for large B-cell lymphoma with CNS involvement : a GLA/DRST study
    In: Blood Advances, Jg. 7, 2023, Nr. 18, S. 5316 – 5319
    DOI (Open Access)
  • Salles, Gilles; Schuster, Stephen J.; Fischer, Luca; Kuruvilla, John; Patten, Piers E. M.; von Tresckow, Bastian; Smith, Sonali; Ubieto, Ana Jiménez; Davis, Keith L.; Nagar, Saurabh; Zhang, Jie; Bollu, Vamsi; Jousseaume, Etienne; Ramos, Roberto; Wang, Yucai; Link, Brian K.
    A Retrospective Cohort Study of Treatment Outcomes of Adult Patients With Relapsed or Refractory Follicular Lymphoma (ReCORD-FL)
    In: HemaSphere: Open Access Journal of the European Hematology Association, Jg. 6, 2022, Nr. 7, S. e745
    DOI (Open Access)
  • Sasse, Stephanie; Bröckelmann, Paul Jan; Momotow, Jesko; Plütschow, Annette; Hüttmann, Andreas; Basara, Nadezda; Koenecke, Christian; Martin, Sonja; Bentz, Martin; Grosse-Thie, Christina; Thorspecken, Sven; de Wit, Maike; Kobe, Carsten; Dietlein, Markus; von Tresckow, Bastian; Fuchs, Michael; Borchmann, Peter; Engert, Andreas
    AFM13 in patients with relapsed or refractory classical Hodgkin lymphoma : final results of an open-label, randomized, multicenter phase II trial
    In: Leukemia and Lymphoma, 2022
    DOI
  • Damaschin, Carla; Goergen, Helen; Kreissl, Stefanie; Plütschow, Annette; Breywisch, Frank; Mathas, Stephan; Meissner, Julia; Sökler, Martin; Topp, Max S.; Vucinic, Vladan; Zimmermann, Andreas; von Tresckow, Bastian; Fuchs, Michael; Engert, Andreas; Borchmann, Peter; Eichenauer, Dennis A.
    Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma : follow-up analysis of a randomized phase II study from the German Hodgkin Study Group
    In: Leukemia, Jg. 36, 2022, Nr. 2, S. 580 – 582
    DOI (Open Access)
  • Bröckelmann, Paul J.; Müller, Horst; Gillessen, Sarah; Yang, Xiaoqin; Koeppel, Larissa; Pilz, Veronika; Marinello, Patricia; Kaskel, Peter; Raut, Monika; Fuchs, Michael; Borchmann, Peter; Engert, Andreas; von Tresckow, Bastian
    Clinical outcomes of relapsed and refractory Hodgkin lymphoma patients after contemporary first-line treatment : A German Hodgkin Study Group analysis
    In: Leukemia, Jg. 36, 2022, Nr. 3, S. 772 – 780
    DOI (Open Access)
  • Ullrich, Fabian; Hanoun, Christine; Turki, Amin T.; Liebregts, Tobias; Breuckmann, Katharina; Alashkar, Ferras; Reinhardt, Hans Christian; von Tresckow, Bastian; von Tresckow, Julia
    Early report on the severity of COVID-19 in hematologic patients infected with the SARS-CoV2 omicron variant
    In: European Journal of Haematology, Jg. 109, 2022, Nr. 4, S. 364 – 372
    DOI (Open Access)
  • Salles, Gilles; Schuster, Stephen J.; Dreyling, Martin; Fischer, Luca; Kuruvilla, John; Patten, Piers E.M.; von Tresckow, Bastian; Smith, Sonali M.; Jiménez-Ubieto, Ana; Davis, Keith L.; Anjos, Carla; Chu, Jufen; Zhang, Jie; Lobetti Bodoni, Chiara; Thieblemont, Catherine; Fowler, Nathan H.; Dickinson, Michael; Martínez-López, Joaquin; Wang, Yucai; Link, Brian K.
    Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma
    In: Blood Advances, Jg. 6, 2022, Nr. 22, S. 5835 – 5843
    DOI (Open Access)
  • Bethge, Wolfgang A.; Martus, Peter; Schmitt, Michael; Holtick, Udo; Subklewe, Marion; von Tresckow, Bastian; Ayuk, Francis; Wagner-Drouet, Eva Marie; Wulf, Gerald G.; Marks, Reinhard; Penack, Olaf; Schnetzke, Ulf; Koenecke, Christian; von Bonin, Malte; Stelljes, Matthias; Glass, Bertram; Baldus, Claudia D.; Vucinic, Vladan; Mougiakakos, Dimitrios; Topp, Max; Fante, Matthias A.; Schroers, Roland; Bayir, Lale; Borchmann, Peter; Buecklein, Veit; Hasenkamp, Justin; Hanoun, Christine; Thomas, Simone; Beelen, Dietrich W.; Lengerke, Claudia; Kroeger, Nicolaus; Dreger, Peter
    GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany
    In: Blood, Jg. 140, 2022, Nr. 4, S. 349 – 358
    DOI (Open Access)
  • Eichenauer, Dennis A.; Bühnen, Ina; Kreissl, Stefanie; Goergen, Helen; Fuchs, Michael; von Tresckow, Bastian; Rosenwald, Andreas; Klapper, Wolfram; Hansmann, Martin-Leo; Möller, Peter; Bernd, Heinz-Wolfram; Feller, Alfred C.; Engert, Andreas; Borchmann, Peter; Hartmann, Sylvia
    Histopathological growth patterns in patients with advanced nodular lymphocyte-predominant Hodgkin lymphoma treated within the randomized HD18 study : A report from the German Hodgkin Study Group
    In: British Journal of Haematology, Jg. 196, 2022, Nr. 1, S. 99 – 104
    DOI (Open Access)
  • Graef, Claus Moritz; Gödel, Philipp; Falderbaum, Philipp; Balke‐Want, Hyatt; Simon, Florian; Sieg, Noëlle; Naendrup, Jan‐Hendrik; Neumann, Marie Anne‐Catherine; Gillessen, Sarah; Bröckelmann, Paul J.; Eichenauer, Dennis A.; Borchmann, Peter; von Tresckow, Bastian; Heger, Jan‐Michel
    Impact of timing and precision of histopathological diagnosis on outcomes of patients with Burkitt lymphoma and high‐grade B‐cell lymphoma
    In: European Journal of Haematology, Jg. 108, 2022, Nr. 5, S. 403 – 412
    DOI (Open Access)
  • Seifert, Robert; Kersting, David; Rischpler, Christoph; Sandach, Patrick; Ferdinandus, Justin; Fendler, Wolfgang; Rahbar, Kambiz; Weckesser, Matthias; Umutlu, Lale; Hanoun, Christine; Hüttmann, Andreas; Reinhardt, Hans Christian; von Tresckow, Bastian; Herrmann, Ken; Dührsen, Ulrich; Schäfers, Michael
    Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification : A post-hoc analysis of the PETAL trial
    In: Leukemia, Jg. 36, 2022, Nr. 12, S. 2845 – 2852
    DOI (Open Access)
  • Gillessen, Sarah; Pluetschow, Annette; Vucinic, Vladan; Ostermann, Helmut; Kobe, Carsten; Bröckelmann, Paul J.; Böll, Boris; Eichenauer, Dennis A.; Heger, Jan-Michel; Borchmann, Sven; Fuchs, Michael; Borchmann, Peter; Engert, Andreas; von Tresckow, Bastian
    JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma : Final results of a phase II, open label, multicentre clinical trial (JeRiCHO)
    In: European Journal of Haematology, Jg. 109, 2022, Nr. 6, S. 728 – 735
    DOI (Open Access)
  • Bröckelmann, Paul J.; von Tresckow, Bastian; Engert, Andreas
    Neue Ansätze zur Behandlung des rezidivierten oder refraktären Hodgkin Lymphoms
    In: Die Onkologie, Jg. 28, 2022, Nr. 10, S. 901 – 907
    DOI
  • Momotow, Jesko; Bühnen, Ina; Trautmann-Grill, Karolin; Kobbe, Guido; Hahn, Dennis; Schroers, Roland; Heinrich, Bernhard; Gaska, Tobias; Forstbauer, Helmut; Schmidt, Burkhard; Boger, Regina; Hüttmann, Andreas; Heil, Gerhard; Kraemer, Doris M.; Krüger, William; Zeremski, Vanja; Grobe, Norbert; Jentsch-Ullrich, Kathleen; Griesinger, Frank; Fuchs, Michael; von Tresckow, Bastian; Borchmann, Peter; Engert, Andreas; Bröckelmann, Paul J.
    Outcomes of anti-programmed death 1 treatment for relapsed/refractory Hodgkin lymphoma : A German Hodgkin Study Group multicentre real-world analysis
    In: British Journal of Haematology, Jg. 198, 2022, Nr. 2, S. 401 – 404
    DOI (Open Access)
  • Eichenauer, Dennis A.; Bühnen, Ina; Plütschow, Annette; Kobe, Carsten; Dietlein, Markus; Wendtner, Clemens‐Martin; Thorspecken, Sven; Topp, Max S.; Mauser, Mareike; von Tresckow, Bastian; Fuchs, Michael; Borchmann, Peter; Engert, Andreas
    Phase II study of fixed‐duration single‐agent ibrutinib in relapsed nodular lymphocyte‐predominant Hodgkin lymphoma : A report from the German Hodgkin Study Group
    In: Hematological Oncology, Jg. 40, 2022, Nr. 4, S. 801 – 804
    DOI
  • Gillessen, Sarah; Hüttmann, Andreas; Vucinic, Vladan; Müller, Horst; Plütschow, Annette; Viardot, Andreas; Topp, Max S.; Kobe, Carsten; Böll, Boris; Eichenauer, Dennis A.; Sasse, Stephanie; Haverkamp, Heinz; Schmitz, Christine; Borchmann, Sven; Bröckelmann, Paul J.; Heger, Jan-Michel; Fuchs, Michael; Engert, Andreas; Borchmann, Peter; von Tresckow, Bastian
    Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma : An experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD-R3i)
    In: British Journal of Haematology, Jg. 196, 2022, Nr. 3, S. 606 – 616
    DOI (Open Access)
  • Fowler, Nathan Hale; Dickinson, Michael; Dreyling, Martin; Martinez-Lopez, Joaquin; Kolstad, Arne; Butler, Jason; Ghosh, Monalisa; Popplewell, Leslie; Chavez, Julio C.; Bachy, Emmanuel; Kato, Koji; Harigae, Hideo; Kersten, Marie José; Andreadis, Charalambos; Riedell, Peter A.; Ho, P. Joy; Pérez-Simón, José Antonio; Chen, Andy I.; Nastoupil, Loretta J.; von Tresckow, Bastian; Ferreri, Andrés José María; Teshima, Takanori; Patten, Piers E. M.; McGuirk, Joseph P.; Petzer, Andreas L.; Offner, Fritz; Viardot, Andreas; Zinzani, Pier Luigi; Malladi, Ram; Zia, Aiesha; Awasthi, Rakesh; Masood, Aisha; Anak, Oezlem; Schuster, Stephen J.; Thieblemont, Catherine
    Tisagenlecleucel in adult relapsed or refractory follicular lymphoma : The phase 2 ELARA trial
    In: Nature Medicine, Jg. 28, 2022, Nr. 2, S. 325 – 332
    DOI, Online Volltext (Open Access)
  • Voltin, Conrad-Amadeus; Mettler, Jasmin; van Heek, Lutz; Goergen, Helen; Müller, Horst; Baues, Christian; Keller, Ulrich; Meissner, Julia; Trautmann-Grill, Karolin; Kerkhoff, Andrea; Fuchs, Michael; Sasse, Stephanie; von Tresckow, Bastian; Dietlein, Markus; Borchmann, Peter; Engert, Andreas; Kobe, Carsten; Bröckelmann, Paul J.
    Early response to first-line anti–PD-1 treatment in hodgkin lymphoma : A PET-based analysis from the prospective, randomized phase II NIVAHL trial
    In: Clinical Cancer Research, Jg. 27, 2021, Nr. 2, S. 402 – 407
    DOI (Open Access)
  • Plattel, Wouter J.; Bergamasco, Aurore; Trinchese, Fabrizio; Gavini, François; Bent-Ennakhil, Nawal; Zomas, Athanasios; Castillon, Genaro; Arredondo-Bisono, Teigna; Cristarella, Tiffany; Moride, Yola; von Tresckow, Bastian
    Effectiveness of brentuximab vedotin monotherapy in relapsed or refractory Hodgkin lymphoma : a systematic review and meta-analysis
    In: Leukemia and Lymphoma, Jg. 62, 2021, Nr. 14, S. 3320 – 3332
    DOI (Open Access)
  • Jachimowicz, Ron D.; Klapper, Wolfram; Glehr, Gunther; Müller, Horst; Haverkamp, Heinz; Thorns, Christoph; Hansmann, Martin Leo; Möller, Peter; Stein, Harald; Rehberg, Thorsten; von Tresckow, Bastian; Reinhardt, H.C.; Borchmann, Peter; Chan, Fong Chun; Spang, Rainer; Scott, David W.; Engert, Andreas; Steidl, Christian; Altenbuchinger, Michael; Rosenwald, Andreas
    Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP
    In: Leukemia, Jg. 35, 2021, Nr. 12, S. 3589 – 3593
    DOI (Open Access)
  • Sobesky, Sophia; Mammadova, Laman; Cirillo, Melita; Drees, Esther E.E.; Mattlener, Julia; Dörr, Helge; Altmüller, Janine; Shi, Zhiyuan; Bröckelmann, Paul J.; Weiss, Jonathan; Kreissl, Stefanie; Sasse, Stephanie; Ullrich, Roland T.; Reinke, Sarah; Klapper, Wolfram; Gerhard-Hartmann, Elena; Rosenwald, Andreas; Roemer, Margaretha G.M.; Nürnberg, Peter; Hagenbeek, Anton; Zijlstra, Josée M.; Pegtel, Dirk Michiel; Engert, Andreas; Borchmann, Peter; von Tresckow, Bastian; Borchmann, Sven
    In-depth cell-free DNA sequencing reveals genomic landscape of Hodgkin's lymphoma and facilitates ultrasensitive residual disease detection
    In: Med, Jg. 2, 2021, Nr. 10, S. 1171 – 1193.e11
    DOI (Open Access)
  • Gillessen, Sarah; Plütschow, Annette; Fuchs, Michael; Markova, Jana; Greil, Richard; Topp, Max S; Meissner, Julia; Zijlstra, Josée M; Eichenauer, Dennis A; Bröckelmann, Paul J; Diehl, Volker; Borchmann, Peter; Engert, Andreas; von Tresckow, Bastian
    Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma : long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14)
    In: The Lancet Haematology, Jg. 8, 2021, Nr. 4, S. e278 – e288
    DOI
  • Eichenauer, Dennis A.; Müller, Horst; Elger, Leonard; Goergen, Helen; Fuchs, Michael; Kreissl, Stefanie; Böll, Boris; Diehl, Volker; von Tresckow, Bastian; Borchmann, Peter; Engert, Andreas
    Non-Hodgkin lymphoma after treatment for classical Hodgkin lymphoma : A report from the German Hodgkin Study Group
    In: British Journal of Haematology, Jg. 193, 2021, Nr. 3, S. 515 – 519
    DOI (Open Access)
  • Eichenauer, D.A.; Kreissl, S.; Bühnen, I.; Baues, C.; Kobe, C.; van Heek, L.; Goergen, H.; Fuchs, M.; Hartmann, S.; von Tresckow, Bastian; Engert, A.; Borchmann, P.
    PET-2-guided escalated BEACOPP for advanced nodular lymphocyte-predominant Hodgkin lymphoma : a subgroup analysis of the randomized German Hodgkin Study Group HD18 study
    In: Annals of Oncology, Jg. 32, 2021, Nr. 6, S. 807 – 810
    DOI (Open Access)
  • Borchmann, Peter; Plütschow, Annette; Kobe, Carsten; Greil, Richard; Meissner, Julia; Topp, Max S; Ostermann, Helmut; Dierlamm, Judith; Mohm, Johannes; Thiemer, Julia; Sökler, Martin; Kerkhoff, Andrea; Ahlborn, Miriam; Halbsguth, Teresa V; Martin, Sonja; Keller, Ulrich; Balabanov, Stefan; Pabst, Thomas; Vogelhuber, Martin; Hüttmann, Andreas; Wilhelm, Martin; Zijlstra, Josée M; Moccia, Alden; Kuhnert, Georg; Bröckelmann, Paul J; von Tresckow, Bastian; Fuchs, Michael; Klimm, Beate; Rosenwald, Andreas; Eich, Hans; Baues, Christian; Marnitz, Simone; Hallek, Michael; Diehl, Volker; Dietlein, Markus; Engert, Andreas
    PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17) : a multicentre, open-label, randomised, phase 3 trial
    In: The Lancet Oncology, Jg. 22, 2021, Nr. 2, S. 223 – 234
    DOI
  • von Tresckow, Julia; von Tresckow, Bastian; Reinhardt, H. Christian; Herrmann, Ken; Berliner, Christoph; Herrmann, Ken
    Thymic hyperplasia after mRNA based Covid-19 vaccination
    In: Radiology Case Reports, Jg. 16, 2021, Nr. 12, S. 3744 – 3745
    DOI (Open Access)
  • Sieg, Noëlle; Naendrup, Jan-Hendrik; Gödel, Philipp; Balke-Want, Hyatt; Simon, Florian; Deckert, Martina; Gillessen, Sarah; Kreissl, Stefanie; Bröckelmann, Paul J.; Borchmann, Peter; von Tresckow, Bastian; Heger, Jan-Michel; Tresckow, Bastian
    Treatment patterns and disease course of previously untreated Primary Central Nervous System Lymphoma : Feasibility of MTX-based regimens in clinical routine
    In: European Journal of Haematology, Jg. 107, 2021, Nr. 2, S. 202 – 210
    DOI (Open Access)
  • Goereci, Y.; Schweitzer, F.; Wellstein, A.; Silling, S.; Borchmann, S.; von Tresckow, Bastian; Adams, O.; Martin, R.; Schlamann, Marc; Schroeter, M.; Fink, G.R.; Wattjes, M.P.; Warnke, C.
    Clearance of JC polyomavirus from cerebrospinal fluid following treatment with interleukin-2 and pembrolizumab in an individual with progressive multifocal leukoencephalopathy and no underlying immune deficiency syndrome
    In: European Journal of Neurology, Jg. 27, 2020, Nr. 11, S. 2375 – 2377
    DOI (Open Access)
  • Bröckelmann, Paul J.; Goergen, Helen; Keller, Ulrich; Meissner, Julia; Ordemann, Rainer; Halbsguth, Teresa V.; Sasse, Stephanie; Sökler, Martin; Kerkhoff, Andrea; Mathas, Stephan; Hüttmann, Andreas; Bormann, Matthias; Zimmermann, Andreas; Mettler, Jasmin; Fuchs, Michael; von Tresckow, Bastian; Baues, Christian; Rosenwald, Andreas; Klapper, Wolfram; Kobe, Carsten; Borchmann, Peter; Engert, Andreas
    Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma : The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial
    In: JAMA Oncology, Jg. 6, 2020, Nr. 6, S. 872 – 880
    DOI, Online Volltext (Open Access)
  • Bröckelmann, Paul J.; von Tresckow, Bastian
    Risk stratification and prognostic biomarkers in relapsed Hodgkin lymphoma
    In: British Journal of Haematology, Jg. 190, 2020, Nr. 6, S. 813 – 814
    DOI (Open Access)
  • Reinke, Sarah; Bröckelmann, Paul J.; Iaccarino, Ingram; Garcia-Marquez, Maria; Borchmann, Sven; Jochims, Franziska; Kotrova, Michaela; Pal, Karol; Brüggemann, Monika; Hartmann, Elena; Sasse, Stephanie; Kobe, Carsten; Mathas, Stephan; Soekler, Martin; Keller, Ulrich; Bormann, Matthias; Zimmermann, Andreas; Richter, Julia; Fuchs, Michael; von Tresckow, Bastian; Borchmann, Peter; Schlößer, Hans; Bergwelt-Baildon, Michael von; Rosenwald, Andreas; Engert, Andreas; Klapper, Wolfram
    Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1
    In: Blood, Jg. 136, 2020, Nr. 25, S. 2851 – 2863
    DOI (Open Access)
  • Fuchs, Michael; Goergen, Helen; Kobe, Carsten; Kuhnert, Georg; Lohri, Andreas; Greil, Richard; Sasse, Stephanie; Topp, Max S.; Schäfer, Erhardt; Hertenstein, Bernd; Soekler, Martin; Vogelhuber, Martin; Zijlstra, Josée M.; Keller, Ulrich Bernd; Krause, Stefan W.; Wilhelm, Martin; Maschmeyer, Georg; Thiemer, Julia; Dührsen, Ulrich; Meissner, Julia; Viardot, Andreas; Eich, Hans; Baues, Christian; Diehl, Volker; Rosenwald, Andreas; von Tresckow, Bastian; Dietlein, Markus; Borchmann, Peter; Engert, Andreas
    Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma : Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group
    In: Journal of Clinical Oncology (JCO), Jg. 37, 2019, Nr. 31, S. 2835 – 2845
    DOI (Open Access)
  • Klimm, Beate C.; Goergen, Helen; Fuchs, Michael G.G.; von Tresckow, Bastian; Böll, Boris; Meissner, Julia; Glunz, Axel; Diehl, Volker; Eich, Hans Theodor; Engert, Andreas; Borchmann, Peter
    Impact of risk factors on outcomes in early-stage Hodgkin's lymphoma: An analysis of international staging definitions
    In: Annals of Oncology, Jg. 24, 2013, Nr. 12, S. 3070 – 3076
    DOI

    • Abstracts

  • Pabst, Kim; Bartel, Timo; Sandach, Patrick; Weber, Manuel; Laschinsky, Christina; Eckstein, Markus; Kessler, Lukas; Kueper, Alina; Hadaschik, Boris; Kesch, Claudia; Hamacher, Rainer; Nader, Michael; Siveke, Jens; von Tresckow, Bastian; Kümmel, Sherko; Podleska, Lars; Reinacher-Schick, Anke; Uhl, Waldemar; Herrmann, Ken; Fendler, Wolfgang
    68Ga-FAPI-46 PET for Imaging of FAP-expressing Cancer : Results from a Prospective, Single-Arm, Interventional Phase 2 Clinical Trial
    In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 66, 2025, Nr. Supplement 1, 251524
    Online Volltext (Open Access)
  • Gagelmann, Nico; Stölzel, Friedrich; Fenk, Roland; Holderried, Tobias A.W.; Mueller, Fabian; Tovar, Natalia; Oliver-Caldés, Aina; Rathje, Kristin; Vucinic, Vladan; Kharboutli, Soraya; Bärmann, Ben-Niklas; Ayuk, Francis A.; Platzbecker, Uwe; Albici, Anca Maria; Schub, Natalie; Schmitz, Friederike; Khandanpour, Cyrus; Teichert, Marcel; Jeker, Barbara; Kroeger, Nicolaus; von Tresckow, Bastian; Fernandez de Larrea, Carlos; Pabst, Thomas; Merz, Maximilian
    Cilta-Cel Is Associated with Improved Outcomes and Distinct Cellular Dynamics Compared with Ide-Cel for Relapsed or Refractory Multiple Myeloma
    In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 144, 2025, Nr. Suppl. 1, S. 2004 – 2005
    DOI (Open Access)
  • Merz, Maximilan; Dima, Danai; Hashmi, Hamza; Mueller, Fabian; Ahmed, Nausheen; Rathje, Kristin; Davis, James; Holderried, Tobias; Vucinik, Vladan; Kharbouti, Soraya; Ayuk, Francis; Stoelzel, Friedrich; Schub, Natalie; Schmitz, Friederike; Shune, Leyla; Khouri, Jack; Anwer, Faiz; McGuirk, Joseph; Teichert, Marcel; von Tresckow, Bastian; Kroeger, Nicolaus; Pabst, Thomas; Abdallah, Al-Ola; Gagelmann, Nico
    Bispecific Antibodies Improve Outcomes in Patients With Relapsed or Refractory Multiple Myeloma After Car-T Cell Therapy
    In: Clinical Lymphoma, Myeloma & Leukemia. ‎New York: Elsevier, Jg. 24, 2024, Nr. Suppl. 2, S. S73 – S74
    DOI
  • Bröckelmann, Paul J.; Böll, Boris; Molin, Daniel; Schneider, Gundolf; Leppä, Sirpa; Meissner, Julia; Kamper, Peter; Hutchings, Martin; Christensen, Jacob Haaber; Schnetzke, Ulf; Fuchs, Michael; Eichenauer, Dennis A; von Tresckow, Bastian; Kaul, Helen; Borchmann, Peter; Fossa, Alexander
    Brentuximab Vedotin, Cyclophosphamide, Doxorubicin and Prednisone (B-CAP) First-Line Treatment of Advanced-Stage Hodgkin Lymphoma : Final Results of the GHSG-NLG Phase II Bvb Trial
    66th ASH Annual Meeting; December 7-10, 2024; San Diego, USA,
    In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 144, 2024, Nr. Supplement 1, S. 3054 – 3054
    DOI (Open Access)
  • Thieblemont, Catherine; Dreyling, Martin; Dickinson, Michael J.; Martínez-Lopez, Joaquín; Kolstad, Arne; Butler, Jason; Ghosh, Monalisa; Popplewell, Leslie L.; Chavez, Julio C.; Bachy, Emmanuel; Kato, Koji; Harigae, Hideo; Kersten, Marie José; Andreadis, Charalambos; Riedell, Peter A.; Ho, Phoebe Joy; Pérez-Simón, Jose Antonio; Chen, Andy; Nastoupil, Loretta; von Tresckow, Bastian; Ferreri, Andrés José María; Teshima, Takanori; Patten, Piers E.M.; McGuirk, Joseph P.; Offner, Fritz; Viardot, Andreas; Zinzani, Pier Luigi; Malladi, Ram; Zia, Aiesha; Awasthi, Rakesh; Germano, Davide; Ramos, Roberto Javier; Hsu, Pei; Schuster, Stephen J.; Fowler, Nathan H.
    Clinical Outcomes of Patients with High-Risk Relapsed/Refractory Follicular Lymphoma Treated with Tisagenlecleucel : Phase 2 ELARA 4-Year Update
    The 66th ASH Annual Meeting, December 7-10, 2024, San Diego, USA,
    In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 144, 2024, Nr. Supplement 1, S. 3034
    DOI (Open Access)
  • Berning, Philipp; Maulhardt, Markus; Boyadzhiev, Hristo; Albici, Anca Maria; Janjetovic, Snjezana; Ossami Saidy, Anna; Schultze-Florey, Christian R; Call, Simon; Schub, Natalie; Brioli, Annamaria; Daskalakis, Michael; Knust, Juliane; Hasenkamp, Justin; Stelljes, Matthias; Khandanpour, Cyrus; Bacher, Ulrike; Hanoun, Christine; Heidel, Florian; Reinhardt, Christian; Lenz, Georg; Wulf, Gerald; Stölzel, Friedrich; von Tresckow, Bastian; Pabst, Thomas; Shumilov, Evgenii
    Idecabtagene Vicleucel (ide-cel) Shows Similar Efficacy and Toxicity in Patients with Multiple Myeloma Aged 70 and Older Compared to Younger Patients : A Multicenter Cohort Study
    The 66th ASH Annual Meeting, December 7-10, 2024, San Diego, USA,
    In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 144, 2024, Nr. Supplement 1, S. 3383
    DOI (Open Access)
  • Ferdinandus, Justin; Kaul, Helen; Fosså, Alexander; Hüttmann, Andreas; Keil, Felix; Ko, Yon-Dschun; Hitz, Felicitas; Schwarz, Michaela; Trenker, Corinna; Kerkhoff, Andrea; Staib, Peter; Wille, Kai; Dresel, Irmgard; Hahn, Dennis; Hertenstein, Bernd; Moosmann, Peter; Mey, Ulrich; Balabanov, Stefan; Armytage, Tasman; Roncolato, Fernando; Hellmuth, Johannes Christian; Kreissl, Stefanie; Fuchs, Michael; Schneider, Gundolf; Tharmaseelan, Hishan; Eichenauer, Dennis A; von Tresckow, Bastian; Borchmann, Peter; Bröckelmann, Paul J.
    PET-Guided Brecadd in Older Patients with Advanced-Stage Classic Hodgkin Lymphoma : Results of the Phase 2 Part of the GHSG HD21 Trial
    The 66th ASH Annual Meeting, December 7-10, 2024, San Diego, USA,
    In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 144, 2024, Nr. Supplement 1, S. 568 – 568
    DOI (Open Access)
  • Christofyllakis, Konstantinos; Age Kos, Igor; Altmann, Bettina; Poeschel, Viola; Maurer, Stephanie; Lesan, Vadim; Bittenbring, Jörg-Thomas; Kaddu-Mulindwa, Dominic; Abdi, Zanir; Ahlgrimm, Manfred; Altmeyer, Sarah; Fleser, Octavian; Held, Gerhard; Nickelsen, Maike; Dreyling, Martin; Zettl, Florian; Buske, Christian; Lenz, Georg; Glass, Bertram; Chapuy, Björn; Schmitz, Norbert; Ott, German; Siebert, Reiner; Viardot, Andreas; Scherer, Florian; Schmitz, Roland; Rosenwald, Andreas; Hellwig, Dirk; Neuendorff, Nina; Vassilakopoulos, Theodoros; Doxani, Chrysoula; Blatt, Pascal; Nakisli, Oguzhan; Schmidt, Susanne; Gaska, Tobias; Arndt, Börge; Mueller, Matthias; Witte, Hanno Maximilian; Bentz, Martin; Boehme, Volkmar; Kirchen, Heinz; Loeffler, Markus; Kubuschock, Boris; Gebauer, Niklas; Mahlberg, Rolf; Topaly, Julian; Bott, Alexander; Wille, Kai; Trappe, Ralf Ulrich; Rummel, Mathias J.; Illerhaus, Gerald; Brunner, Franziska; Klump, Martin; Kaiser, Ulrich; Wessendorf, Swen; Deligiannis, Iordanis; Hildebrandt, Bert; Kiani, Alexander; Illmer, Thomas; Prange-Krex, Gabriele; Lerch, Kristina; Sandmann, Matthias; Broeckling, Sebastian; Martens, Uwe; von Tresckow, Bastian; Heine, Annkristin; Hebart, Holger F.; Stilgenbauer, Stephan; Thurner, Lorenz; Bewarder, Moritz; Ziepert, Marita
    Safety of Front-Line R-Mini-CHOP with or without Acalabrutinib in Older Adults with DLBCL - an Interim Analysis of Serious Adverse Events in the Arched / GLA 2022-1 Randomized, Open-Label, Phase 3 Trial
    The 66th ASH Annual Meeting, December 7-10, 2024, San Diego, USA,
    In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 144, 2024, Nr. Supplement 1, S. 4498
    DOI (Open Access)
  • Shumilov, Evgenii; Wurm-Kuczera, Rebecca; Vucinic, Vladan; Seib, Maximilian; Holtick, Udo; Mazzeo, Paolo; Scholz, Julia Katharina; Boyadzhiev, Hristo; Melchardt, Thomas; Hölscher, Alexander; Schultze-Florey, Christian R; Velazquez, Giuliano Filippini; Ossami Saidy, Anna; Lesan, Vadim; Schnetzke, Ulf; Kerkhoff, Andrea; Bacher, Ulrike; Ghandili, Susanne; Aydilek, Enver; Gebauer, Niklas; Weber, Thomas; Wulf, Gerald; Glass, Bertram; Thurner, Lorenz; Heidel, Florian; Schmid, Christoph; Viardot, Andreas; Hänel, Mathias; Dietrich, Sascha; Pabst, Thomas; Ayuk, Francis A.; von Tresckow, Bastian; Chapuy, Björn; Pott, Christiane; Mueller, Fabian; Lenz, Georg
    Time of CAR-T Failure Is a Strong Predictor of Outcome for Bispecific Antibody Therapy in Relapsed/Refractory Large B-Cell Lymphoma
    In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 144, 2024, Nr. Supplement 1, S. 114 – 114
    DOI (Open Access)
  • Mueller, Fabian; Patel, Krish; Reshef, Ran; Cherry, Mohamad; Nash, Richard; Ayala, Ernesto; Hsu, Jingmei; Azzi, Jacques; Vandenberghe, Peter; Houot, Roch; von Tresckow, Bastian; Stifano, Giuseppina; Koegel, Ashley; Falcon, Susana; Chaudhry, Burhan; Kelly, Lisa; Thorpe, Jerill; Frisbee, Alyse; Charab, Sam; Das, Sharmila; Ly, Thomas; Ogasawara, Ken; Caimi, Paolo
    Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of BMS-986353 (CC-97540), a CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy Manufactured Using a Next-Generation Process, for Severe, Refractory Autoimmune Diseases : Updated Data from Ongoing Phase 1, Multicenter, Open-Label Studies
    The 66th ASH Annual Meeting, December 7-10, 2024, San Diego, USA,
    In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 144, 2024, Nr. Supplement 1, S. 2088
    DOI (Open Access)
  • Siefen, AC; Kurte, M.S.; Jakobs, F.; Teichert, M.; von Tresckow, Bastian; Reinhardt, HC; Kron, F.
    Towards a Frictionless CAR-T Therapy Process : Identifying and Prioritizing Procedural Preconditions for Oncologic Institutions Using Group Concept Mapping
    ISPOR Europe 2024, 17 - 20 November, Barcelona,
    In: Value in Health. New York; Malden, Mass.: Elsevier, Jg. 27, 2024, Nr. 12, Supplement ISPOR Europe 2024, S. S341 – S341
    DOI
  • Fan, J.; Adams, A.; Sieg, N.; Heger, J.; Gödel, P.; Kutsch, N.; Kaul, D.; Teichert, M.; von Tresckow, Bastian; Bücklein, V.; Goesmann, G.; Li, M.; Struve, N.; Trommer, M.; Linde, P.; Rosenbrock, J.; Celik, E.; Penack, O.; Stuschke, Martin; Subklewe, M.; Belka, C.; von Bergwelt-Baildon, M.; Borchmann, P.; Marnitz, S.; Baues, C.
    A multicentric retrospective analysis of the potential synergy between radiotherapy and CAR T-cells
    ESTRO 2023 ; 13 - 16 May 2023, Vienna, Austria,
    In: Radiotherapy and Oncology (The Green Journal). Amsterdam: Elsevier, Jg. 182, 2023, Nr. Supplement 1, S. S800 – S801
    DOI
  • Höfmann, Svenja; Flümann, Ruth; Hansen, Julia; Klein, Sebastian; Meinel, Jörn; Pfeiffer, Pauline; Goldfarb-Wittkopf, Hannah; Lütz, Anna; Wirtz, Jessica; Möllmann, Michael; Zhou, Tanja; Tabatabai, Areya; Lohmann, Tim; Beleggia, Filippo; Pelzer, Benedikt; Ullrich, Fabian; Arora, Aastha; Persigehl, Thorsten; Büttner, Reinhard; von Tresckow, Bastian; Jachimowicz, Ron; Knittel, Gero; Reinhardt, Hans Christian
    An In Vivo PiggyBac Insertional Mutagenesis Screen Reveals Oncogenic Lesions Cooperating with Myd88 L265P
    65th ASH Annual Meeting, December 9-12, 2023, San Diego, CA, USA,
    In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 142, 2023, Nr. Supplement 1, S. 525 – 526
    DOI (Open Access)
  • Schuster, Stephen J.; Fowler, Nathan; Dickinson, Michael; Martinez-Lopez, Joaquin; Kolstad, Arne; Butler, Jason; Ghosh, Monalisa; Popplewell, Leslie L.; Chavez, Julio C; Bachy, Emmanuel; Kato, Koji; Harigae, Hideo; Kersten, Marie José; Andreadis, Charalambos; Riedell, Peter A; Ho, Phoebe Joy; Perez-Simon, Jose A.; Chen, Andy; Nastoupil, Loretta J.; von Tresckow, Bastian; Ferreri, Andrés José María; Teshima, Takanori; Patten, Piers; McGuirk, Joseph P; Petzer, Andreas L; Offner, Fritz; Viardot, Andreas; Zinzani, Pier Luigi; Malladi, Ram; Zia, Aiesha; Awasthi, Rakesh; Paule, Ines; Germano, Davide; Ramos, Roberto Javier; Hsu, Pei; Thieblemont, Catherine; Dreyling, Martin
    Clinical Outcomes of Patients with Relapsed/Refractory Follicular Lymphoma Treated with Tisagenlecleucel : Phase 2 Elara 3-Year Follow-up
    65th Annual Meeting of the American-Society-of-Hematology (ASH); DEC 09-12, 2023; San Diego, USA,
    In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 142, 2023, Nr. Suppl. 1, S. 601 – 601
    DOI (Open Access)
  • Bröckelmann, P.; Müller, H.; Gillessen, S.; Jacob, A. S.; Momotow, J.; Damaschin, C.; Ferdinandus, J.; Yang, X.; Fuchs, M.; Kobe, C.; Eich, H. T.; Engert, A.; Borchmann, P.; von Tresckow, Bastian
    Correlation between progression-free and overall survival in patients with classical Hodgkin lymphoma : a comprehensive analysis of individual patient data from randomized GHSG trials
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 46, 2023, Nr. Supplement 5: DGHO Abstracts, S. 110
    DOI (Open Access)
  • Laube, A.; Fuhrmann, S.; Peczynski, C.; Boumendil, A.; Michel, E.; Finel, H.; Galimard, J.; Beauvais, D.; Daskalakis, M.; Novak, U.; Kröger, N.; Stelljes, M.; von Tresckow, Bastian; Wulf, G.G.; Dreger, P.; Sureda, A.; Schmitz, N.; Glaß, B.
    Efficacy and toxicity of CAR T‐cell therapy in patients with primary and secondary central nervous system lymphoma : an analysis of the EBMT Lymphoma WP and the GoCART coalition
    In: Hematological Oncology. Hoboken: Wiley-Blackwell - STM, Jg. 41, 2023, Nr. S2, 17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023, S. 454 – 456
    DOI (Open Access)
  • Ossami Saidy, A.; Fuhrmann, S.; Peczynski, C.; von Tresckow, Bastian; Glass, B.; et al.
    Efficacy of CAR T cell therapy in patients with primary or secondary CNS lymphoma : an analysis of the EBMT Lymphoma Working Party and the GoCART coalition
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 46, 2023, Nr. Supplement 5: DGHO Abstracts, S. 22 – 23
    DOI (Open Access)
  • Ossami Saidy, Anna; Fuhrmann, Stephan; Peczynski, Christophe; Boumendil, Ariane; Michel, Eva; Galimard, Jacques-Emmanuel; Finel, Hervé; Daskalakis, Michael; Novak, Urban; Beauvais, David; Vandenberghe, Peter; Kröger, Nicolaus; Ram, Ron; Finke, Jürgen; Stelljes, Matthias; Wulf, Gerald G.; Bethge, Wolfgang Andreas; von Bonin, Malte; Bug, Gesine; Kuhnl, Andrea; Passweg, Jakob; Stoelzel, Friedrich; von Tresckow, Bastian; Sureda Balari, Anna Maria; Dreger, Peter; Schmitz, Norbert; Glass, Bertram
    Efficacy of CD19-Directed CAR T Cell Therapy in Patients with Primary or Secondary CNS Lymphoma : An Analysis of the EBMT Lymphoma WP and the Gocart Coalition
    65th Annual Meeting of the American-Society-of-Hematology (ASH); DEC 09-12, 2023; San Diego, USA,
    In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 142, 2023, Nr. Supplement 1, S. 1031 – 1033
    DOI (Open Access)
  • Ferdinandus, J.; Cirillo, M.; Bröckelmann, P. J.; von Tresckow, Bastian; Klapper, W.; Engert, A.; Borchmann, P.; Borchmann, S.
    Soluble immune checkpoints HVEM and TIM-3 are prognostic biomarkers for outcome in classical Hodgkin lymphoma
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 46, 2023, Nr. Supplement 5: DGHO Abstracts, S. 111
    DOI (Open Access)
  • Ferdinandus, J.; Cirillo, M.; Bröckelmann, P.J.; von Tresckow, Bastian; Klapper, W.; Engert, A.; Borchmann, P.; Borchmann, S.
    Soluble immune checkpoints HVEM and TIM‐3 are prognostic biomarkers for outcome in classical Hodgkin lymphoma
    In: Hematological Oncology. Hoboken: Wiley-Blackwell - STM, Jg. 41, 2023, Nr. S2, 17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023, S. 315 – 316
    DOI (Open Access)
  • Derigs, P.; Bethge, W.; Holtick, U.; von Tresckow, Bastian; Ayuk, F.; Penack, O.; Vucinic, V.; von Bonin, M.; Baldus, C.; Mougiakakos, D.; Wulf, G.; Schnetzke, U.; Stelljes, M.; Thomas, S.; Schroers, R.; Kroeger, N.; Dreger, P.
    Faktoren assoziiert mit Langzeitüberleben nach Versagen einer chimären Antigen-Rezeptor (CAR) T-Zell-Therapie für rezidivierte oder refraktäre großzellige B-Zell-Lymphome : eine Rolle für die allogene Stammzelltransplantation?
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 45, 2022, Nr. Supplement 2, S. 169
    DOI (Open Access)
  • Voltin, C.; Gödel, P.; Beckmann, L.; Heger, J.; Kobe, C.; Kutsch, N.; Borchmann, P.; Dietlein, M.; Herrmann, Ken; Stelljes, M.; Rahbar, K.; Lenz, G.; Reinhardt, Hans Christian; Teichert, M.; Noppeney, Richard; Albring, J. C.; Seifert, R.; von Tresckow, Bastian; Floßdorf, S.; Hanoun, Christine
    Metabolic Tumor Volume for Outcome Prediction in Patients with Large B-Cell Lymphoma Undergoing Chimeric Antigen Receptor T-Cell Treatment
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S211
    DOI (Open Access)
  • Bröckelmann, Paul J.; Bühnen, Ina; Meissner, Julia; Trautmann-Grill, Karolin; Herhaus, Peter; Halbsguth, Teresa V.; Schaub, Valdete; Kerkhoff, Andrea; Mathas, Stephan; Bormann, Matthias; Dickhut, Andreas; Kaul, Helen; Fuchs, Michael; Kobe, Carsten; Baues, Christian; Borchmann, Peter; Engert, Andreas; von Tresckow, Bastian
    Nivolumab and AVD in Early-Stage Unfavorable Hodgkin Lymphoma : Follow-up Analysis of the Randomized GHSG Phase II Nivahl Trial
    64th ASH Annual Meeting and Exposition, 10-13 December 2022, New Orleans,
    In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 140, 2022, Nr. Supplement 1: 64th ASH Annual Meeting Abstracts, S. 1753 – 1755
    DOI (Open Access)
  • Heger, Jan-Michel; Mattlener, Julia; Gödel, Philipp; Balke-Want, Hyatt; Sieg, Noëlle; Kutsch, Nadine; Becker, Kerstin; Weiss, Jonathan; Reinhardt, H. Christian; Hallek, Michael; Borchmann, Peter; von Tresckow, Bastian; Borchmann, Sven
    Noninvasive, Dynamic Risk Profiling of Primary Central Nervous System Lymphoma By Peripheral Blood Ctdna-Sequencing
    64th ASH Annual Meeting, December 10-13, 2022, New Orleans, LA, USA,
    In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 140, 2022, Nr. Suppl. 1, S. 3537 – 3538
    DOI (Open Access)
  • Flümann, Ruth; Hansen, Julia; Pelzer, Benedikt; Kisis, Ilmars; Lohmann, Tim; Persigehl, Thorsten; Abedpour, Nima; Peifer, Martin; Buettner, Reinhard; von Tresckow, Bastian; Jachimowicz, Ron; Reinhardt, Hans Christian; Knittel, Gero
    Novel Autochthonous Mouse Models of Serve As Preclinical Tools to Investigate Pathogenesis and Treatment of MCD/C5 DLBCL
    64th ASH Annual Meeting and Exposition, 10-13 December 2022, New Orleans, LA, USA,
    In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 140, 2022, Nr. Supplement 1: 64th ASH Annual Meeting Abstracts, S. 3493 – 3494
    DOI (Open Access)
  • Ernst, M.; Dührsen, U.; Ott, G.; Held, G.; Lenz, G.; Trümper, L.; Hellwig, D.; Poeschel, V.; Eich, H. T.; Oertel, M.; Glass, B.; von Tresckow, Bastian; Chapuy, B.; Thiemer, J.; Horneber, M.; Simon, S. T.; Skoetz, N.; Borchmann, P.
    S3 - Leitlinie zur Diagnostik, Therapie und Nachsorge für erwachsene Patient*innen mit einem diffusen großzelligen B-Zell-Lymphom und verwandten Entitäte
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 45, 2022, Nr. Supplement 2, S. 51
    DOI (Open Access)
  • Gagelmann, N.; Dreger, P.; Düll, J.; Reinhardt, Christian; von Tresckow, Bastian; Kröger, N.; et al.
    Stem cell boost for persistent cytopenia after chimeric antigen receptor t-cell therapy : A German Lymphoma alliance (GLA) study
    48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), March 19-23, 2022, Virtual,
    In: Bone Marrow Transplantation. London: Springer Nature, Jg. 57, 2022, Nr. Suppl. 1, S. 30 – 31
    Online Volltext (Open Access)
  • Hirmas, N.; Ingenwerth, M.; Sraieb, Miriam; Kessler, Lukas; Pabst, K. M.; Lanzafame, H.; Lückerath, Katharina; Kasper, Stefan; Nader, M.; Schildhaus, Hans-Ulrich; Hadaschik, Boris; Grünwald, Viktor; von Tresckow, Bastian; Hanoun, Christine; Aigner, Clemens; Glas, Martin; Herrmann, Ken; Siveke, Jens T.; Hamacher, R.; Fendler, Wolfgang P.
    Target Expression and FAP-Directed Tumour Imaging in a Large, Single-Centre PET Database of 324 Patients and 21 Tumour Entities
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S119 – S120
    DOI (Open Access)
  • Armand, Philippe; Kuruvilla, John; Herrera, Alex F.; Ribrag, Vincent; Brice, Pauline; Thieblemont, Catherine; von Tresckow, Bastian; Kim, Eunhee; Orlowski, Robert; Chakraborty, Samhita; Marinello, Patricia; Zinzani, Pier Luigi Luigi
    Characterizing Safety in Patients with Hematologic Malignancies Receiving Allogeneic Stem Cell Transplant (Allo-SCT) Following Pembrolizumab Therapy
    63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,
    In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 138, 2021, Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 3924 – 3927
    DOI (Open Access)
  • Bröckelmann, P.; Müller, H.; Gillessen, S.; Yang, X.; Köppel, L.; Pilz, V.; Marinello, P.; Kaskel, P.; Raut, M.; Fuchs, M.; Borchmann, P.; Engert, A.; von Tresckow, Bastian; German Hodgkin Study Group (GHSG)
    Clinical outcomes of relapsed Hodgkin lymphoma patients after contemporary first-line treatment : Results from the German Hodgkin Study Group (GHSG)
    Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 44, 2021, Nr. Supplement 2, S. 37
    DOI (Open Access)
  • Salles, Gilles; Schuster, Stephen J.; Dreyling, Martin H.; Fischer, Luca; Kuruvilla, John; Patten, Piers EM; von Tresckow, Bastian; Smith, Sonali M.; Jiminez Ubieto, Ana Isabel; Davis, Keith L.; Anjos, Carla; Chu, Jufen; Zhang, Jie; Lobetti Bodoni, C; Thieblemont, Catherine; Fowler, Nathan H.; Dickinson, Michael; Martinez-Lopez, Joaquin; Wang, Yucai; Link, Brian K.
    Efficacy Comparison of Tisagenlecleucel Versus Standard of Care in Patients with Relapsed or Refractory Follicular Lymphoma
    63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,
    In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 138, 2021, Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 3528 – 3531
    DOI (Open Access)
  • Armand, Philippe; Zinzani, Pier Luigi Luigi; Lee, Hun Ju; Johnson, Nathalie; Brice, Pauline; Radford, John; Ribrag, Vincent; Molin, Daniel; Vassilakopoulos, Theodoros P.; Tomita, Akihiro; von Tresckow, Bastian; Shipp, Margaret A.; Herrera, Alex F.; Lin, Jianxin; Kim, Eunhee; Chakraborty, Samhita; Marinello, Patricia; Moskowitz, Craig H.
    Five-Year Follow-up of Keynote-087 : Pembrolizumab Monotherapy in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL)
    63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,
    In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 138, 2021, Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 1366 – 1369
    DOI (Open Access)
  • von Tresckow, Bastian
    Hodgkin Lymphoma : First line therapy (focus on early unfavorable disease) ; recommendations in the light of current literature
    Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 44, 2021, Nr. Supplement 2, S. 6
    DOI (Open Access)
  • Heger, Jan-Michel; Graef, Claus Moritz; Falderbaum, Philipp; Gödel, Philipp; Balke-Want, Hyatt; Simon, Florian; Sieg, Noëlle; Naendrup, Jan-Hendrik; Neumann, Marie Anne-Catherine; Gillessen, Sarah; Bröckelmann, Paul J; Eichenauer, Dennis A.; Borchmann, Peter; von Tresckow, Bastian
    Impact of Timing and Precision of Histopathological Diagnosis on Outcomes of Patients with Burkitt and High-Grade B-Cell Lymphoma
    63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,
    In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 138, 2021, Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 2531 – 2532
    DOI (Open Access)
  • Dreger, Peter; Schubert, Maria-Luisa; Holtick, Udo; Subklewe, Marion; von Tresckow, Bastian; Ayuk, Francis A.; Wagner, Eva Maria; Wulf, Gerald; Marks, Reinhard; Penack, Olaf; Schnetzke, Ulf; Koenecke, Christian; Von Bonin, Malte; Stelljes, Matthias; Glass, Bertram; Baldus, Claudia D.; Vucinic, Vladan; Mougiakakos, Dimitrios; Topp, Max; Wolff, Daniel; Schroers, Roland; Borchmann, Peter; Rejeski, Kai; Hanoun, Christine; Lengerke, Claudia; Thomas, Simone; Beelen, Dietrich W.; Kröger, Nicolaus; Bethge, Wolfgang A
    Late Non-Relapse Mortality (NRM) after Standard-of-Care (SOC) CAR-T Cell Therapy for Large B-Cell Lymphoma (LBCL) : Frequency, Causes, and Risk Factors.a GLA/DRST Real World Analysis
    63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,
    In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 138, 2021, Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 1748 – 1751
    DOI (Open Access)
  • Momotow, Jesko; Bühnen, Ina; Trautmann-Grill, Karolin; Kobbe, Guido; Wilhelm, Martin; Heinrich, Bernhard; Gaska, Tobias; Forstbauer, Helmut; Schmidt, Burkhard; Hüttmann, Andreas; Heil, Gerhard; Kraemer, Doris M.; Krüger, William Hermann; Zeremski, Vanja; Grobe, Norbert; Jentsch-Ulrich, Kathleen; Fuchs, Michael; von Tresckow, Bastian; Borchmann, Peter; Engert, Andreas; Bröckelmann, Paul J.
    Outcomes of Anti-PD1 Treatment for Relapsed/Refractory Hodgkin Lymphoma : A German Hodgkin Study Group (GHSG) Multi-Center Real-World Analysis
    63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,
    In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 138, 2021, Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 4533 – 4535
    DOI (Open Access)
  • von Tresckow, Bastian
    Relapsed and Refractory HL : Innovative Therapies
    8th International Congress on Leukemia Lymphoma Myeloma, 21.-22.05.2021, Virtual,
    In: Turkish Journal of Hematology. Ankara: Turkish Society of Hematology, Jg. 38, 2021, Nr. Supplement 1, S. S24 – S24
    Online Volltext (Open Access)
  • Bethge, Wolfgang A; Martus, Peter; Schmitt, Michael; Holtick, Udo; Borchmann, Peter; Subklewe, Marion; Rejeski, Kai; von Tresckow, Bastian; Ayuk, Francis A.; Kroeger, Nicolaus; Wagner-Drouet, Eva-Maria; Wulf, Gerald; Marks, Reinhard; Penack, Olaf; Schnetzke, Ulf; Koenecke, Christian; Von Bonin, Malte; Stelljes, Matthias; Glass, Bertram; Baldus, Claudia D.; Vucinic, Vladan; Mougiakakos, Dimitrios; Topp, Max; Wolff, Daniel; Schroers, Roland; Thomas, Simone; Beelen, Dietrich W.; Lengerke, Claudia; Dreger, Peter
    Standard of Care CAR-T Cell Therapy for Large B-Cell Lymphoma (LBCL) : Does Bridging Efficacy Matter? A German GLA/DRST Real World Analysis
    63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,
    In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 138, 2021, Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 3822 – 3825
    DOI (Open Access)
  • Eichenauer, Dennis A.; Bühnen, Ina; Fuchs, Michael; Kaul, Helen; Kobe, Carsten; Hartmann, Sylvia; Baues, Christian; von Tresckow, Bastian; Borchmann, Peter; Engert, Andreas
    Treatment of Early-Stage Nodular Lymphocyte-Predominant Hodgkin Lymphoma : A Subgroup Analysis of the Randomized German Hodgkin Study Group HD16 Study
    63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,
    In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 138, 2021, Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 2439 – 2440
    DOI (Open Access)
  • Momotow, J.; Sasse, S.; Plütschow, A.; Hüttmann, Andreas; Basara, N.; Könecke, C.; Martin, S.; Bentz, M.; Große-Thie, C.; Thorspecken, S.; Wit, M. de; Kobe, C.; Dietlein, M.; von Tresckow, Bastian; Fuchs, M.; Borchmann, P.; Engert, A.
    AFM13 in patients with relapsed or refractory Hodgkin Lymphoma : Final results of an open-label, randomized, multicenter phase II trial
    Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 43, 2020, Nr. Suppl. 4, S. 89
    DOI (Open Access)
  • von Tresckow, Bastian; Bergamasco, Aurore; Trinchese, Fabrizio; Gavini, Frank; Bent-Ennakhil, Nawal; Zomas, Athanasios; Castillon, Guillaume; Arredondo-Bisono, Teigna; Cristarella, Teresa; Moride, Yola; Plattel, W.J.
    Effectiveness of brentuximab vedotin in relapsed/refractory classic Hodgkin lymphoma : A systematic review and meta-analysis
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 31, 2020, Nr. Suppl. 4, S. S650
    DOI (Open Access)
  • Bröckelmann, Paul J; Goergen, Helen; Keller, Ulrich; Meissner, Julia; Ordemann, Rainer; Halbsguth, Teresa V; Sasse, Stephanie; Sökler, Martin; Kerkhoff, Andrea; Mathas, Stephan; Hüttmann, Andreas; Bormann, Matthias; Zimmermann, Andreas; Fuchs, Michael; von Tresckow, Bastian; Baues, Christian; Rosenwald, Andreas; Klapper, Wolfram; Kobe, Carsten; Borchmann, Peter; Engert, Andreas
    Nivolumab and AVD for Early-Stage Unfavorable Hodgkin Lymphoma (NIVAHL)
    61st ASH (American Society of Hematology) Annual Meeting & Exposition; Dec 07 - 10 2019; Orlando, USA,
    In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 134, 2019, Nr. Supplement_1: 61st ASH Annual Meeting, S. 236 – 236
    DOI (Open Access)
  • Fuchs, M.; Görgen, H.; Kobe, C.; Kuhnert, G.; Hitz, F.; Greil, R.; Sasse, S.; Topp, M. S.; Schäfer, E.; Hertenstein, B.; Sökler, M.; Vogelhuber, M.; Zijlstra, J. M.; Keller, U. B.; Krause, S. W.; Wilhelm, M.; Maschmeyer, G.; Thiemer, J.; Dührsen, U.; Meissner, J.; Viardot, A.; Eich, H.; Baues, C.; Diehl, V.; Rosenwald, A.; von Tresckow, Bastian; Dietlein, M.; Borchmann, P.; Engert, A.
    Pet positivity after 2 cycles of abvd is a risk factor in patients with early-stage favorable Hodgkin lymphoma treated in the phase 3 GHSG HD16 study
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 42, 2019, Nr. Supplement 4: Abstracts, S. 297
    DOI (Open Access)
  • von Tresckow, Bastian; Hüttmann, Andreas; Vucinic, Vladan; Mueller, Horst; Plütschow, Annette; Viardot, Andreas; Topp, Max S.; Kobe, Carsten; Böll, Boris; Eichenauer, Dennis A.; Sasse, Stephanie; Haverkamp, Heinz; Fuchs, Michael; Engert, Andreas; Borchmann, Peter
    Induction Therapy with Everolimus in Combination with DHAP (Dexamethasone, High-Dose AraC, Cisplatinum) in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma : A Randomized, Placebo-Controlled Phase I/II Trial (HD-R3i)
    60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,
    In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 132, 2018, Nr. Supplement 1, S. 2912 – 2912
    DOI (Open Access)

    • Poster / Posterbeiträge

  • Pabst, Kim M.; Bartel, Timo; Sandach, Patrick; Laschinsky, Christina; Weber, Manuel M.; Kessler, Lukas; Küper, Alina T.; Hadaschik, Boris A.; Kesch, Claudia; Hamacher, Rainer; Kasper, Stefan; Podleska, Lars E.; Siveke, Jens T.; Eckstein, Markus; von Tresckow, Bastian; Kuemmel, Sherko; Reinacher-Schick, Anke; Uhl, Waldemar; Herrmann, Ken; Fendler, Wolfgang P.
    68Ga-FAPI-46 PET/CT for cancer imaging : Results of a single-center, prospective, interventional, single-arm clinical trial
    2025 ASCO Genitourinary Cancers Symposium, February 13-15, 2025, San Francisco, CA, USA,
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 43, 2025, Nr. 5, Supplement, 457
    DOI
  • Maulhardt, Markus; Berning, Philipp; Hanoun, Christine; Boyadzhiev, Hristo; Albici, Anca Maria; Janjetovic, Snjezana; Ossami Saidy, Anna; Call, Simon; Schub, Natalie; Aydilek, Enver; Daskalakis, Michael; Jung, Wolfram; Hasenkamp, Justin; Krekeler, Carolin; Khandanpour, Cyrus; Bacher, Ulrike; Reinhardt, Hans Christian; Lenz, Georg; Stölzel, Friedrich; Wulf, Gerald; Pabst, Thomas; von Tresckow, Bastian; Shumilov, Evgenii
    Efficacy of Idecabtagene Vicleucel (ide-cel) in Patients with Relapsed/Refractory Multiple Myeloma and Prior Central Nervous System Manifestation: A Retrospective Real-World Analysis
    66th ASH Annual Meeting, December 7-10, 2024, San Diego, CA, USA,
    In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 144, 2024, Nr. Supplement 1, S. 4759 – 4760
    DOI (Open Access)
  • Dreyling, M.; Dickinson, M.; Martinez-Lopez, J.; von Tresckow, Bastian; Schuster, S. J.; et al.
    Long-term Clinical Outcomes and Correlative Efficacy Analyses in Patients (Pts) with Relapsed/Refractory (r/r) Follicular Lymphoma (FL) treated with Tisagenlecleucel in the ELARA Trial
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 46, 2023, Nr. Supplement 5: DGHO Abstracts, S. 306 – 308
    DOI (Open Access)
  • von Tresckow, Bastian; Budde, L. E.; Bartlett, N. L.; Sehn, L. H.; et al.
    Subcutaneous mosunetuzumab is active with a manageable safety profile in patients (pts) with Relapsed/Refractory (R/R) B-cell non-Hodgkin Lymphomas (B-NHL) : updated results from a Phase I/II study
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 46, 2023, Nr. Supplement 5: DGHO Abstracts, S. 206 – 207
    DOI (Open Access)
  • Garcia Borrega, J.; Heindel, K.; Schmid, C.; von Tresckow, Bastian; Reinhardt, Christian; Marks, R.; Luther, M. L.; Ayuk, F.; Wichmann, D.; Beutel, G.; Obstfelder, E.; Schnetzke, U.; Schub, N.; Baldus, C.; Subklewe, M.; von Bergwelt, M.; Viardot, A.; Schellongowski, P.; Böll, B.
    RICarT : Registry for immune-effector and CAR T associated toxicities
    Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 44, 2021, Nr. Supplement 2, S. 258
    DOI (Open Access)